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SUMMARY 
Stress is an important modulator of cognition. Cognitive dysfunctions in some 
neuropsychiatric disorders, such as schizophrenia, are associated with stress. 
Recently, evidence has emerged that a brain stem structure, the nucleus 
incertus (NI), potentially plays a role in stress and cognition modulation. The 
prominent expression of corticotrophin-releasing factor type 1 receptor (CRF1) 
and recent evidence that physiological stressors increased NI activation, 
suggest its involvement in stress responses. Expression of a variety of peptides, 
neurotransmitters and receptors, notably GABA and relaxin-3 (RLN3), in NI 
has been reported implicating their potential role in NI function. Moreover, 
tract-tracing studies have delineated NI connections to prefrontal cortex (PFC), 
including both the sub-regions of medial prefrontal cortex (mPFC) and 
anterior cingulate cortex (ACC). mPFC plays a pivotal role in mediating 
working memory, while the nearby ACC is indispensible in modulating fear 
memory. Both structures are sensitive to stress. Stress impairs mPFC 
executive function, whereas it initiates ACC fear processing. Our previous 
study revealed that both electrical stimulation of the NI and intra-NI CRF 
infusion suppressed mPFC neuronal firing and hippocampal-medial prefrontal 
cortical long term potentiation (HP-mPFC LTP), but increased ACC neuronal 
firing. Based on these results, we hypothesized that the NI plays a critical role 
in cognition under stress, especially in PFC modulation. To test the hypothesis: 
(1) The chemoarchitecture of NI neurons projecting to mPFC and ACC was 
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characterized. Results demonstrated high levels of expression of CRF1 
receptor, RLN3 and dopamine D2S in NI cells labeled in PFC retrograde 
tracing studies, indicating direct innervation by the NI in PFC modulation 
under stress and the potential involvement of RLN3 and dopaminergic 
systems in the modulation process. In addition, the newly developed 
technology CLARITY was preliminary established for further NI mapping and 
chemoarchitecture studies. (2) The role of the NI in stressor-induced 
HP-mPFC LTP modulation was validated by first establishing optimal stress 
models and then investigating the effects of intra-NI CRF1 antagonist 
treatment on HP-mPFC LTP in rats exposed to stress model. In vivo 
electrophysiology results demonstrated that CRF1 antagonist treatment in NI 
could block the suppression effect on HP-mPFC LTP caused by elevation 
stress, suggesting the participation of NI in stressor-induced mPFC 
modulation. (3) The role of the NI in stress-induced mPFC working memory 
behavior modulation was studied. Although further study is required to 
strengthen the evidence, our results implicated that the NI might mildly impair 
mPFC working memory examined by a delayed spatial win-shift task and CRF 
treatment. Therefore, this study suggested the critical role of NI in PFC 
modulation under stress, and implicated the NI as a potential therapeutic target 
for amelioration of cognitive dysfunction in neuropsychiatric disorders. 
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Chapter 1   
Introduction 
 
1. Stress and cognition 
1.1 Stress 
Nowadays, stress is a common topic in our daily life. Stress could be defined as a 
threat to the physiological or psychological integrity of an individual and may initiate 
a cascade of adaptive physiological, psychological and behavioral changes. The 
adaptive processes involve a myriad of alterations in physiological, neuroendocrine 
and immune systems (McEwen, 2000; Seymour Levine, 2005). There are two major 
systems that mediate the stress response. The first is the 
hypothalamic-pituitary-adrenal (HPA) system, which stimulates the adrenal cortex to 
release glucocorticoids, and modulates cell physiology and behavior response by 
intracellular signaling mechanisms. The second stress mediator is the 
sympathetic-adrenomedullary system that triggers the release of adrenaline and 
nonadrenaline. These mediators help the organisms to adapt to stressors and to restore 
homeostasis (Fuchs et al., 2006). However, failing to restore the homeostasis might 
lead to deleterious results for the organism (McEwen, 2007).  
 
1.2 Effects of stress on cognition 
Despite adaptation being the main purpose of the stress response, susceptibility to 
stress varies. In vulnerable individuals, stress could be deleterious and a risk factor 
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for psychopathology (Schwabe and Wolf, 2013). Stress is considered to be an 
important modulator of cognitive functions, especially learning and memory. There 
are various outcomes of stress on cognition. Depending on the stressors and the brain 
regions modulated, stress may either impair or facilitate cognition (Sandi and 
Pinelo-Nava, 2007). Intensive work has focused on the structural and functional 
changes in the cooperative and competitive memory systems, in particular in the 
hippocampus, prefrontal cortex and amygdala (Fuchs et al., 2006). Notably, recent 
research implicates the potential role of an emerging structure, the nucleus incertus 
(NI) in stress and memory modulation (Ryan et al., 2011).  
  
2. Nucleus Incertus 
The nucleus incertus (NI) has only relatively recently attracted the interest of 
neuroscientists. With years of research, more and more structural and functional 
characters of the NI are revealed. 
2.1 NI anatomy 
The NI in the rat is located in the prepontine periventricular gray area. In an adult rat, 
the nucleus extends for ~0.7mm from -9.12mm to -9.84mm caudal to Bregma. The 
NI is divided into two sub-regions, the pars compacta (NIc) and pars dissipata (NId). 
The NIc lies near the midline, which extends from the caudal pole of the dorsal raphe 
nucleus to the caudal end of the periventricular gray in the preontine region, while the 
NId lies laterally to the NIc which contains a distinct group of more loosely arranged 
neurons as compared to the NIc (Goto et al., 2001). 
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2.2 NI chemoarchitecture 
More than a decade of research has delineated a group of peptides, neurotransmitters 
and receptors expressed in the NI. NI neurons have been originally characterized by 
the prominent expression of inhibitory neurotransmitter γ-amino-butyric acid 
(GABA), suggesting its inhibitory role in neurotransmission (Ford et al., 1995; Ma et 
al., 2007). Recently, a neuropeptide, relaxin-3 (RLN3), was found to be primarily 
expressed in the NI and strongly co-expressed with GABA (Tanaka et al., 2005; Lein 
et al., 2007; Ma et al., 2007). The cognate receptor for RLN3 is Relaxin family 
peptide receptor 3 (RXFP3), which is a G-protein coupled receptor that couples to 
inhibitory Gi/o proteins (Liu et al., 2003; van der Westhuizen et al., 2007). Regarding 
the receptors, although fewer studies reported the receptor distribution in NI, a 
majority of NI neurons express corticotrophin-releasing factor type 1 receptors 
(CRF1). Corticotrophin-releasing factor (CRF) is a stress peptide that integrates the 
complex neuroendocrine functions and adaptive behaviors in response to stress (Juan 
et al., 2011). CRF takes action by activating CRF type 1 or type 2 receptors. 
Therefore, the prominent expression of CRF1 receptor in NI strongly implicates its 
role in the stress response (Ven Pett et al., 2007). Other receptors such as 5HT1A 
(Miyamoto et al., 2008) and dopamine D2 (unpublished data from our laboratory; see 
Chapter 3) were also expressed in NI. 
 
2.3 NI connections 
Besides studies of the chemoarchitecture of the NI, the neuroanatomical connections 
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of the NI throughout the brain have also been mapped by tract tracing studies. The 
two independent comprehensive mappings of the NI connections by Goto et al (2001) 
and Olucha-Bordonau et al (2003) are largely in accord. The major outputs of the NI 
are to the hippocampal formation, medial septal nucleus and amygdala. Moreover, 
studies also showed its projections to medial prefrontal cortex (mPFC) and anterior 
cingulate cortex (ACC), which are two crucial structures for cognition, working 
memory and fear memory, respectively (Goto et al., 2001; Olucha-Bordonau et al., 
2003; Hoover and Vertes, 2007). 
 
2.4 NI and stress response 
Although the functions of the NI are not yet well studied, the widespread connections 
of the NI suggest its prospective role in multiple physiological processes. Based on 
the prominent expression of CRF1 the NI was originally speculated to participate in 
stress responses. Recent evidence further implied its critical role in stress modulation. 
Intracerebroventricular injection of CRF and acute stressors (including restraint, 
forced swim and water immersion) both activated the NI as indicated by significant 
induction of immediate early gene c-Fos expression (Tanaka et al., 2005; Cullinan et 
al., 1995; Banerjee et al., 2010). RLN3 mRNA levels were also rapidly increased 
following swim stress (Banerjee et al., 2010). In addition, current studies also indicate 
that the NI may play a role in modulating theta rhythm and arousal. However, a small 
brain stem nucleus such as the NI is not likely to directly control higher functions 
such as learning and memory, hence, it may regulate these functions through 
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interaction with forebrain areas, such as hippocampus, prefrontal cortex and 
amygdala. 
3. Stress and PFC 
3.1 Stress and mPFC 
The prefrontal cortex (PFC), which is often referred as a “mental sketch pad”, plays a 
pivotal role in mediating a range of executive functions that subserve the modulation 
of behavior, thought and emotion in response to environment demands, including 
working memory, temporal processing, planning, flexibility, and decision making 
(Kesner and Churchwell, 2011). Anatomically, the rodent PFC is comprised of three 
sub-regions, anterior cingulate cortices (ACC), medial prefrontal cortex (mPFC) and 
orbital prefrontal cortex (OFC).  
 
mPFC plays a major role in modulating cognitive functions, especially working 
memory and cognitive flexibility, by integrating complex information from the limbic, 
hippocampal, cortical and brainstem (Homes and Wellman, 2009). However, it is 
extremely vulnerable to stress. Even mild stress can profoundly alter the structure and 
neuronal morphology of mPFC (Arnsten, 2009). A number of studies have examined 
the effects of stress on mPFC-mediated working memory and cognitive flexibility. 
Rodents exposed to restraint, cold water or unpredictable stress showed impaired 
working memory in the Morris water maze, radial arm maze and delayed alternation 
T-maze tasks, as well as impaired reversal learning and set-shifting, which represents 
cognitive flexibility, in attentional set-shifting task (Graybeal et al., 2012). With 
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respect to mPFC neural circuitry, it has been relatively well studied that synaptic 
plasticity, including long-term potentiation (LTP) of the hippocampal-prelimbic 
medial prefrontal cortical (HP-mPFC) pathway strongly participate in various 
cognitive functions, including working memory (Godsil et al., 2013). HP-mPFC 
pathway originates from the CA1 and the ventral subiculum of the hippocampal 
formation and terminates in the mPFC (Jay et al., 1996; Lim et al., 2010). Despite its 
significant effect in cognition, this pathway is also highly sensitive to stress (Godsil et 
al., 2013). 
 
3.2 Stress and ACC 
The ACC, another sub-region of PFC, is located just dorsal to the mPFC, between the 
limbic and cortical structures to integrate emotion and cognition, and plays a key role 
in fear processing, including processing of pain, emotion and threat-related stimuli 
(Bissière, 2008; Zhuo, 2008). Animal studies have identified the critical involvement 
of ACC in the acquisition, storage and consolidation of fear memory (Toyoda et al., 
2011). Trace fear conditioning increased c-Fos mRNA expression in the ACC by 50%. 
Infusion of the excitotoxin NMDA into the ACC reduced freezing in 
trace-fear-conditioned mice, whereas electrical stimulation of the ACC induced fear 
memory (Han et al., 2003; Tang et al., 2005). The ACC might also contribute to 
remote fear memory. Recall of remote contextual fear memory elevated the 
expression of c-Fos in the ACC (Frankland et al., 2006). Hence these results suggest a 
pivotal role of the ACC in fear memory.  
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3.3 Nucleus Incertus and mPFC/ACC 
Interestingly, our previous study demonstrated that both electrical stimulation of the 
NI and intra-NI CRF infusion, as a mimic of the stress condition, resulted in the 
inhibition of mPFC neuron firing and impairment of HP-mPFC pathway LTP (Farooq 
et al., 2013). These results suggest a role for the NI in stress-induced mPFC working 
memory impairments. However, contrary to the effect in mPFC, NI stimulation and 
intra-NI CRF infusion increased ACC firing (unpublished data from our laboratory), 
which implicates its participation in ACC fear memory facilitation. The above 
evidence implies the potential role of NI in stress and memory modulation. However, 
its exact function in the effects of stress on cognition remains unclear. Therefore, this 
project aims to advance understanding of the role of the NI in stress-mediated 
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Chapter 2   
Hypothesis, Aims and Significance of the study 
 
Based on the aforementioned involvement of the NI in stress responses and our 
previous data on NI-mediated regulation of the mPFC and ACC, we hypothesize that 
the NI may play an important role in cognition under stress. NI function under 
stressful conditions may lead to the impairment of mPFC-dependent working 
memory and the facilitation of ACC-mediated fear memory. The main focus of this 
study was on the role of NI in mPFC-dependent modulation under stress. 
 
To validate the proposed hypothesis, we investigated the following research questions 
mainly by tract tracing, in vivo electrophysiology and behavioral studies. 
1. Chemoarchitecture mapping of NI projections to cognition-related brain regions, 
in particular to mPFC and ACC 
2. Role of NI in stress-induced HP-mPFC LTP modulation 
2.1 Establishing the stress models 
2.2 Investigation of the role of the NI in stressor-induced HP-mPFC LTP 
modulation 
3. Role of the NI in stress-induced modulation of mPFC-mediated working memory  
 
The current evidence demonstrates a significant prospective for further investigations 
of the NI functions, especially in stress and memory modulation. These studies may 
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shed light on the better understanding and potential therapeutic treatment of cognitive 
dysfunction in neuropsychiatric disorders. In the previous studies, there is a lack of 
evidence correlating stress and cognition via NI modulation and no study has focused 
on PFC in relation to the NI. Since stress is an indispensible modulator of cognition 
and the PFC is invaluable in controlling executive functions, the scope of this project 
is novel and of great importance. Furthermore, the experimental techniques 
established in this project also open a way to directly manipulate the NI with 
neurochemicals and explore the functions of the NI using in vivo electrophysiological 
and behavioral approaches. This project strengthens our knowledge of the functions 
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Chapter 3  
Chemoarchitecture of NI projections to mPFC and ACC 
 
1. Introduction 
1.1 Retrograde tracing 
Over the past few decades, neuroanatomical tract tracing studies charting the 
interconnections of the nervous system have paved the way for pharmacological, 
physiological and behavioral advances in neuroscience, and have revolutionized 
neurobiology. The most frequently used tracers are based on the common principle of 
axonal transport. With respect to the direction of transport, there are two main 
categories of tracers, anterograde and retrograde. Retrograde tracers are 
macromolecules internalized and transported from axonal terminals to the cell body, 
whereas anterograde tracers are taken up by the cell soma and/or the dendrites, and 
transported along the axon to the synaptic terminals (Lanciego and Wouterlood, 
2011). Therefore, retrograde tracing allows the identification of the origin of the 
afferent neuron populations, while anterograde tracing identifies the target of the 
projections. Fluorogold is a widely used fluorescent retrograde tracer. Fluorogold is 
taken up by axon terminals or injured axons, and retrogradely transported to soma 
and dendrites, labeling the neurons projecting to the injection area. The labeling by 
Fluorogold is specific. It does not diffuse from the labeled neurons, and is not 
transported trans-synaptically (Schumued and Fallon, 1986). Moreover, although 
most tracers have the property of bi-directional transport to some extend, Fluorogold 
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is relatively strictly a retrograde tracer. Besides its specificity, Fluorogold can be 
visualized directly under microscopy with a UV filter (excitation 323nm, emission 
408nm) without additional processing. The color varies slightly with pH: gold at 
neutral and basic pH, while blue at acidic pH. The labeling of Fluorogold is fast, 
strong and stable for a long period of time and even after a variety of fixation and 
histochemical processing treatments (Catapano, et al., 2008).  Based on these 
advantages, Fluorogold is applied in the current project to study the colocalization of 
fluorogold and neuromodulator labeling in the NI and to reveal the chemoarchitecture 
of NI projections. 
 
1.2 NI projections 
As mentioned in the first chapter, the major outputs of the NI are to the hippocampal 
formation, the medial septal nucleus and the amygdala. It also projects to medial 
prefrontal cortex and the anterior cingulate cortex. The two most comprehensive NI 
mapping studies demonstrated similar results. Some fibers labeling was found in the 
infralimbic, prelimbic, and anterior cingulate areas upon anterograde tracing from 
NIc, while only a few fibers ascending fibers were noted in these areas from NId 
(Goto, et al., 2001; Olucha-Bordonau et al., 2003). Retrograde tracer application into 
mPFC also confirmed ascending connections from the NI (Olucha-Bordonau et al., 
2003; Herrero et al., 1997). A recent systematic mapping of afferent projects to the 
mPFC and ACC revealed moderate projections from NI to ACC and light projections 
to mPFC (Hoover and Vertes, 2007). Although the NI-mPFC/ACC connections are 
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not heavy, our previous studies have demonstrated these connections are most likely 
to be functional (see Chapter 1). Therefore, it is valuable to further focus on the 
neurochemical characteristics and physiological functions of these projections. 
 
1.3 NI chemoarchitecture 
The NI neurons contain a plethora of neurotransmitters, peptides and receptors, 
including GABA, Relaxin-3, Neuromedin B, CRF1, 5HT-1a, and mGluR3, to name 
few. Recently, our lab also revealed the expression of dopamine D2 receptors in NI 
neurons.  
CRF1 is prominently expressed in the NI. CRF is a peptide that has a key role in 
neuroendocrine, autonomic, and behavioral responses to stress. It is not only crucial 
in the basal and stress-activated hypothlamic-pituitary-adrenal axis (HPA), but also 
widely distributed and acts as a neuroregulator in extrahypothalamic circuits 
(Bonfiglio et al., 2011). CRF exerts its action through G-protein-coupled receptors 
(GPCRs), CRF1 and CRF2. CRF has high binding affinity to CRF1, but poor binding 
affinity for CRF2. CRF1 has seven transmembrane domains, which are associated with 
several intracellular signaling pathways. Binding of CRF to CRF1 resulted in an 
increase in intracellular cAMP, which activates protein kinase A (PKA) and its 
transcription factor, cAMP response element binding protein (CREB), followed by a 
series of intracellular signal transduction pathways (Arzt and Holsboer, 2006). CRF1 
is prominently expressed in the NI of the rat, but the NI lacks CRF2 (Bittencourt and 
Sawchenko, 2000; Van Pett et al., 2000; Justice et al., 2008). CRF1 positive neurons 
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were evenly distributed throughout the NIc and NId, and 52% of the total NI neuron 
population was positive for CRF1 (Ma et al., 2013). Our previous study revealed the 
effects of intra-NI CRF infusion on mPFC neuronal firing and HP-mPFC LTP, thus a 
key node to understand whether NI directly modulate mPFC/ACC in response to 
stress is to determine whether NI-mPFC/ACC projection neurons express CRF1.  
Furthermore, the NI is also the primary source of RLN3 in the rat (Tanaka et al., 2005; 
Ma et al., 2007). RLN3 is a 5 kDa neuropeptide identified in 2001, which shares the 
same structural characteristics as the relaxin/insulin superfamily peptides (Bathgate et 
al., 2002; Liu et al., 2003). RLN3 is also recognized as the ‘ancestral’ member among 
the relaxin peptide family. It is highly conserved across species, thus suggesting its 
importance in physiological functions (Callander and Bathgate, 2010). RLN3 is 
present in the cytoplasm of NI neurons and in nerve axons, fibers and terminals 
throughout the brain. Mapping studies demonstrated the high overlap of distributions 
of RLN3 projections, its cognate receptor RXFP3 mRNA/binding sites, as well as the 
NI efferents, suggesting a critical role of RLN3 in NI functions (Ryan et al., 2011). In 
the NI, RLN3 positive neurons are densely distributed in the NIc, while diffuse in the 
NId. Comparing RLN3 and CRF1 expression in the NI, all NI RLN3 neurons 
co-express CRF1, however, not all, about 53%, of the NI CRF1 neurons contained 
RLN3. Thus, 28% of the total NI neuronal populations were RLN3 positive (Ma et al., 
2013). A decade of RLN3 research has indicated the potential functions of the RLN3 
neuronal network, such as responses to stress, arousal, food intake, learning and 
memory, and neuroendocrine function. In addition, RLN3 nerve fibers are also 
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distributed in the mPFC and ACC (Ma et al., 2007). Here, we investigated the overlap 
of RLN3 positive neurons with the NI-mPFC/ACC projections to determine whether 
there is potential for RLN3 involvement in the modulation process.  
Regarding the dopamine D2 receptor, only recently, our lab discovered the expression 
of D2 receptors, but not other dopamine receptors, in NI neurons. Dopamine plays a 
role in numerous critical functions. Therefore, dopaminergic dysfunctions are related 
to a multiple diseases, especially Parkinson’s disease and schizophrenia (Beaulieu 
and Gainetdinov, 2011). Dopamine receptors are also GPCRs. There are five distinct 
dopamine receptors, mainly divided into two groups, the D1 and D2 classes (Vallone 
et al., 2000). They are distinguished based on their ability to modulate cAMP 
production and the differences in the pharmacological properties (Kebabian and 
Calne, 1979). D2 receptors couple to the Gαi/o family of G proteins and inhibit 
adenylate cyclase and cAMP production. They are expressed both postsynaptically on 
dopamine target cells and presynaptically on dopaminergic neurons (Rankin et al., 
2010). The two splice variants of the D2 receptors, D2S and D2L distribute 
predominantly presynaptically and postsynaptically, respectively. Activation of 
presynaptic D2S autoreceptors initiate a negative feedback mechanism that leads to a 
decrease in dopamine release, whereas activation of postsynaptic D2L receptors 
stimulates dopamine release (Usiello et al., 2000; De Mei et al., 2009). A more 
detailed characterization revealed that D2S instead of D2L is expressed in the NI. 
However, the function and signaling mechanisms of D2 receptors in the NI are not yet 
investigated. Since the dopaminergic system also plays a vital role in mPFC 
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executive functions, here we studied the expression of D2 receptors in NI-mPFC/ACC 
projections to identify the possible involvement of the dopaminergic system in the 
modulation process. 
1.4 CLARITY 
Although the connections of NI have been mapped by tract tracing studies (Goto et 
al., 2001; Olucha-Bordonau et al., 2003), traditional neuroanatomical study involves 
laborious sectioning and 3D reconstruction processes, which increases the complexity 
and reduces the accuracy. Moreover, NI chemoarchitecture, especially in the NI 
neurons projecting to mPFC/ACC, has not been structurally elucidated. Therefore, an 
advanced approach to delineate a more precise and systematic NI connectivity and 
chemoarchitecture mapping with intact brain is required. Current advanced 
approaches focus on the optical clearing techniques, which render the brain to be 
transparent. The first generation of clearing techniques succeeded in reducing 
variations in refractive index (RI), and thus light scattering, by replacing water with 
organic solvents that match the RI of membrane lipids (Kim et al., 2013). The 
representative reagent is BABB (Dodt et al., 2007). However, such organic solvents 
rapidly quench most fluorescent protein signals. Next came the second generation of 
techniques including Scale, ClearT and SeeDB, which applied aqueous-based 
clearing solutions, (Hama et al., 2011; Kuwajima et al., 2013; Ke et al., 2013). SeeDB 
is the most recently developed method, which clears rapidly without tissue expansion 
and can keep a long lasting (up to 1 week) fluorescent signal (Ke et al., 2013). 
However, it is difficult to clear large volumes of tissue and is not compatible with 
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molecular phenotyping (Kim et al., 2013). To address these challenges, in 2013, a 
third generation of innovative tissue-clearing method was developed, which is named 
CLARITY. CLARITY enables transformation of intact tissue into a nanoporous 
hydrogel-hybridized form that is fully assembled while optically transparent and 
macromolecule-permeable. The clearing process is comprised of three main steps, 
hydrogel monomer infusion, hydrogel-tissue hybridization and electrophoretic tissue 
clearing. After clearing, the lipids that cause light scattering and 
macromolecule-impermeable barriers are removed, while the molecular phenotypes 
are preserved in their physiological location secured by the hydrogel-crosslinked 
matrix (Chung et al., 2013). Although application of CLARITY in rat brain has not 
yet been reported, the optimized method could enable the transformation of the NI 
anterogradely traced brains into optically transparent and be viewed under 
microscope. With CLARITY, the NI innervations of the whole brain could be more 
accurately mapped with relatively intact brain tissue. Moreover, the advantage of 
whole brain immunostaining and imaging after CLARITY process renders the NI 
chemoarchitecture to be delicately depicted, together with the information of NI 
connectivity, may give rise to the better understanding of NI function and the 
underlying mechanisms.  
 
2. Materials and Methods 
2.1 Animals 
Adult male Sprague-Dawley rats (290-350g) obtained from Center for Animal 
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Resources (CARE), National University of Singapore, were maintained in pairs under 
standard housing conditions (21±2°C, 12h light-dark cycle and ad libitum food and 
water). They were acclimatized for 2-3 days before initiation of experiments. All 
procedures were conducted with approval from the Institutional Animal Care and Use 
Committee (IACUC), National University of Singapore, and were in accordance with 
the guidelines of the National Advisory Committee for Laboratory Animal Research 
(NACLAR), Singapore, and the Guide for the Care and Use of Laboratory Animals, 
National Research Council of the National Academies, USA.  
 
2.2 Retrograde tracing 
Rats were anaesthetized with an intraperitoneal injection of a cocktail of ketamine 
(75mg/kg) and xylazine (10mg/kg), mounted on a stereotaxic frame and 
homeothermically maintained throughout surgery. Following a midline sagittal 
incision, burr holes were drilled above the prelimbic area (AP 3.3mm, ML 0.8mm) or 
anterior cingulate cortex area (AP 3.0mm, ML 0.6mm) (Paxinos and Watson, 2007). 
0.2μl of the retrograde tracer Fluorogold (FG; Molecular Probes, Invitrogen; 
Dissolved 4% solution in sterile isotonic saline) was unilaterally infused at a rate of 
0.1μl/min using a 1μl Hamilton syringe and pump assembly targeting mPFC (DV 
3.8mm) or ACC (DV 2.1mm). The needle was left in place for a further 10min before 
being gradually withdrawn. The scalp was sutured and the rats were rehabilitated with 
antibiotic, enrofloxacin (25mg/kg) and analgesic, carprofen (5mg/kg) treatments for 
the first 5 days. On the 8th day after infusion, the rats were sacrificed with an 
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overdose of pentobarbitone (150mg/kg) solution and perfused as detailed below.  
 
2.3 Immunochemistry 
Following 1 week FG infusion, the rats were anaesthetized with pentobarbitone and 
transcardially perfused with 0.9% saline followed by 4% paramaformaldehyde in 
0.1M phosphate buffer. The brain was post-fixed overnight in 4% paraformaldehyde 
and then saturated in 15% and 30% sucrose phosphate-buffered saline (PBS) 
gradually. After saturation, 40μm sections of the NI (AP -9.12~-9.84mm) were taken 
using a cryostat (CM3050; Leica Biosystems, Wetzlar, Germany). Six to eight serial 
sections of NI per brain were further processed for free floating immunofluorescence 
staining of CRF1, RLN3 and D2S. For CRF1 staining, the sections were washed, 
blocked with donkey serum and incubated with anti-CRF1/2 antibody (1:1000; 
sc-1757, Santa Cruz Biotechnology Inc.) overnight at 4°C on a shaker. The sections 
were then washed and incubated with secondary antibody Alexa Fluor 555 donkey 
anti-goat (1:200; Invitrogen) for 1 h at room temperature. Since CRF2 is not 
expressed in rat NI, anti-CRF1/2 was used for CRF1 stainining. For RLN3 and D2S 
staining, the sections were first blocked with goat serum and incubated with primary 
antibody anti-RLN3 antibody (1:400; HK4-144-10, Kizawa et al., 2003) or 
anti-dopamine D2S receptor antibody (1:500; 324396, Calbiochem) overnight at 4°C. 
The secondary antibody used was Alexa Fluor 555 goat anti-rabbit (1:200; 
Invitrogen). Finally, for all the staining, the sections were mounted with ProLong 
Gold Antifade reagent (P36930; Invitrogen) and visualized. All the procedures were 
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performed in the dark to avoid fading of the fluorescence. For verification of the 
infusion sites, 40μm of the corresponding mPFC/ACC sections were directly 
mounted onto coverslips and imaged under fluorescence microscope (BX51; 
Olympus). Only the rats with correct infusion sites in the mPFC or ACC were 
included in the study for quantification. 
 
2.4 Quantification of labeled cells 
The NI sections were visualized under a fluorescence microscope (BX51; Olympus). 
Representative images were captured using fluorescence microscope and confocal 
microscope (LSM510; Carl Zeiss). The outline of the NI was demarcated according 
to the brain atlas (Paxinos and Watson, 2007). Similarly, 6-8 serial sections of NI per 
brain were counted for each antibody staining. The number of cells double labeled 
with retrograde tracer FG and CRF1/2, or RLN3, or D2S were counted, and divided by 
the total number of FG positive neurons in the NI. The values were represented by 
mean±sem. The statistical analysis was carried out using two-way ANOVA 
(GraphPad Prism, USA) comparing the mPFC and ACC for each neurochemical. 
 
2.5 CLARITY 
The CLARITY protocol was adapted from Chung et al (2013) with some 
modifications. The hydrogel solution preparation, clearing solution preparation and 
hydrogel tissue embedding procedures were the same. For hydrogel embedding, 
briefly, a six-weeks-old C57/BL6 adult mouse was deeply anesthetized with 
	   20	  
pentobarbitone and transcardially perfused with PBS and hydrogel solution. The brain 
was harvested and immediately immersed in cold hydrogel solution overnight at 4°C. 
The mouse brain was then de-gassed in a desiccation chamber to replace all of the gas 
in the tube with nitrogen. After nitrogen immersion, the mouse brain tube was 
incubated in 37°C for 3 hours. After hydrogel solution polymerization, the embedded 
mouse brain was extracted from the gel carefully, followed by the wash process. The 
brain was washed with clearing solution for 1 day at room temperature, and two more 
times for 1 day at 37°C to dialyze out extra PFA, initiator and monomer.  
 
After hydrogel embedding and initial washing, the electrophoretic tissue clearing 
(ETC) process was conducted. The ETC chamber was constructed according to the 
instruction. The electrodes were connected to a power pac for electrophoresis, and the 
influx and outflux of the clearing solution were attached to a temperature controlled 
water circulator. The clearing solution was circulated through the chamber with 40V 
applied across the brain at 40°C continually for 3 days to clear the sample. Since the 
water circulator used did not have a cooling function, in our procedure, the clearing 
solution was embedded in ice to prevent the temperature increase caused by heat 
generated during electrophoresis. Therefore, overnight and continuous ETC process 
was not feasible. When ETC process stopped at night time, the brain was immersed in 
clearing solution in room temperature. The continual ETC process lasted for 2 weeks. 
The clearing solution was changed 3 times in between. Since the system still required  
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Figure 3.1 Neuropeptides and receptors in NI neurons projecting to mPFC. (A) FG labelled neurons 
retrogradely traced from mPFC express CRF1/2, from top to bottom showing FG positive neurons, CRF1/2 positive 
neurons, co-localization of FG and positive CRF1/2 neurons and confocal image of co-localization. (B)(C) Similar 
to (A), showing FG labelled neurons express RLN3 and D2S respectively. (D)(E) Schematic and representative 
mPFC FG infusion site. (F) Percentage of CRF1/2/D2S/RLN3 and FG co-localized neurons out of total FG positive 
neurons. Scale bars = 100 μm. Arrows indicate the examples of double labelling. Percentage is represented by 
mean±sem. **P<0.01. 
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3.1 NI projection to mPFC 
To investigate the chemoarchitecture of NI neurons projecting to mPFC, retrograde  
tracer FG was unilaterally infused into the mPFC, specifically in the prelimbic (PL) 
region. The tracer positive neurons in the NI, the expression of neuromodulators, 
including CRF1, RLN3 and D2S in the NI neurons, as well as their co-localization was 
determined. Unilateral infusion of retrograde tracer FG in the PFC resulted in the 
ipsilateral fluorescent FG positive (FG+) NI neurons (161.91±11.65 FG+ cells/ nM2, 
n=8; Fig3.1A-C ). Tracer positive neurons were seen in both NIc and NId. However, 
most of the FG+ neurons distribute in the NIc and only a few in the NId. From 
anterior to posterior regions of the NI, the number and localization of labeled neurons 
were corresponded to the size and shape of NI. The most rostral and caudal sections, 
posterior to the dorsal raphe and anterior of the prepositus nucleus, contain less FG+ 
neurons than the mid-NI sections, which was in consistent with results reported in a 
previous neuroanatomical study (Ma et al., 2013). As a control, in the same coronal 
sections of NI, high density labeling was also seen in the locus coeruleus (LC) region 
and light labeling was seen in the medial longitudinal fasciculus (mlf). Comparing to 
the LC, the NI has moderate projections to the mPFC. The FG+ neurons were 
restricted to these three regions with no extraneous labeling. Moreover, in the nearby 
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regions, positive moderate labeling were also seen in the dorsal raphe nucleus 
anterior to the NI. These suggested the specificity of retrograde labeling from mPFC.  
 
Immunostaining showed the expression of neuromodulators in the NI. The CRF1 
immunoreactivity (IR) was evenly distributed in the NIc and NId. It punctuated and 
outlined the neuronal soma, which is in consistent with the cell membrane 
localization of CRF1 receptors (Ma et al., 2013). In contrast, the RLN3 expression 
was predominantly observed in the NIc, and much less in the NId. The subcellular 
localization of RLN3 IR was also different. It mainly stained the soma of the NI 
neurons, with some dotted-line like fiber staining. The expression and localization of 
CRF1 and RLN3 were in consistent with previously reported (Ma et al., 2013). 
Regarding the D2S IR, it was also evenly distributed throughout the NI. Interestingly, 
the cell membrane located D2S receptors were concentrated in the cell body of the NI 
neurons. The current staining pattern was similar to that reported by Prou et al. (2001) 
who found that most of the synthesized D2S receptors accumulated in large 
intracellular compartments, particularly in the endoplasmic reticulum, while the 
plasma membrane was only weakly labeled.   
 
The colocalization of the retrograde tracer, FG, with CRF1/RLN3/D2S IR was closely 
examined and statistically analyzed. Generally, among the mPFC projecting tracer 
positive NI neurons, high percentages of double labeling for all three 
neuromodulators were observed. Almost all the FG+ neurons were CRF1 and D2S 
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positive, and a large number of FG+ neurons were RLN3 positive (98.16±0.47% n=8, 
98.11±0.35% n=5, 92.19±1.77% n=5 respectively; Fig3.1A-C,F). Bonferroni posthoc 
tests revealed that there were significantly higher proportions of CRF1/FG (P<0.001) 
and D2S/FG (P<0.01) double-labeled neurons than RLN3/FG double-labeled ones in 
the NI upon mPFC FG infusion (Fig 3.1F). Comparing the distribution of the 
double-labeled neurons, there was no specific pattern or area specific localization of 
these neurons in the NI for either of the neuromodulators stained. For counting 
purposes, only rats with injection sites limited to mPFC were included in the study 
(Fig 3.1E). But in some cases where some diffusion to the contralateral mPFC was 
observed, these rats were also included in the immunostaining and analysis. The high 
expression of CRF1/RLN3/D2S in the NI-mPFC projecting neurons indicates that 
these three neuromodulators may participate in the NI modulation of mPFC. The high 
percentage of CRF1/FG double labeling demonstrated that the NI might directly 
regulate of mPFC in response to stress. Moreover, the remarkable expression of 
RLN3/D2S in these NI-mPFC projecting neurons suggests that RLN3 and 
dopaminergic systems may play a role in the modulation process.  
 
3.2 NI projection to ACC 
Similar to the mPFC FG injection, unilateral infusion of retrograde tracer FG into the 
ACC also resulted in ipsilateral fluorescent FG positive NI neurons. However, two 
tailed t-test indicated that there was significantly (p<0.0001) less NI neurons 
projecting to ACC than to mPFC (54.22±4.41 FG+ cells/ nM2; Fig 3.2A-C). Except  
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Figure 3.2 Neuropeptides and receptors in the NI neurons projecting to ACC. (A) FG labelled neurons 
retrogradely traced from ACC express CRF1/2, from top to bottom showing FG positive neurons, CRF1/2 positive 
neurons, co-localization of FG and positive CRF1/2 neurons and confocal image of co-localization. (B)(C) Similar 
to (A), showing FG labelled neurons express RLN3 and D2S respectively. (D)(E) Schematic and representative 
ACC FG infusion site. (F) Percentage of CRF1/2/D2S/RLN3 and FG co-localized neurons out of total FG positive 
neurons. Scale bars = 100 μm. Arrows indicate the examples of double labelling. Percentage is represented by 
mean±sem. **P<0.01. 
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for the number of projection neurons, the distribution and morphology of these 
neurons were similar to NI-mPFC projections, which were more concentrated in NIc, 
while less in NId. 
 
In terms of the co-localization, NI-ACC projections were also similar to NI-mPFC 
projections. Almost all the FG+ neurons were CRF1 and D2S positive, and a large 
number of the FG+ neurons were RLN3 positive (98.06±0.71% n=6, 98.78±0.63% 
n=6, 93.25±1.86% n=5 respectively; Fig3.2A-C,F). The percentage of RLN3+/FG+ 
neurons was significantly different from CRF1+/FG+ (P<0.01) and D2S+/FG+ neurons 
(P<0.01) in NI-ACC projections (Fig3.2F). The infusion site in ACC was verified 
(Fig 3.2E). Only those restricted to the ACC area, without diffusing to mPFC were 
subjected to staining and counting. These results again suggest the potential role of 
the NI in ACC function under stress conditions, as well as the putative participation 
of RLN3 and dopaminergic systems in the process. 
 
Comparing the expression of the three neuromodulators between NI-mPFC and 
NI-ACC projections, two-way ANOVA analysis of all 6 groups revealed that, the type 
of peptide or receptors expressed significantly [F(2,29)=18.30, p<0.0001] affected the 
quantified percentage, while the projection target of mPFC or ACC had no significant 
influence. Therefore, the neuroanatomical evidence demonstrated that NI neurons 
projecting to mPFC or ACC have similar patterns of neuropeptide and receptor 
expressions regarding CRF1, RLN3 and D2S. 
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Figure 3.3 Establishment of CLARITY. (A) CLARITY set up. (B) ETC chamber. (C)-(F) The 
mouse brain after 0h, 36h, 48h and 72h electrophoretic tissue clearing process, showing an increase in 
transparency along the ETC process. (G) Schematic measurement of brain size. (H) Increased size of the 
mouse brain during ETC process.  
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3.3 Establishment of CLARITY 
To depict a more precise and systematic view of NI connectivity and the 
neurochemical characteristics, we tried to establish the newly developed technology 
CLARITY in our lab. The CLARITY equipment and procedures were set up  
according to the protocol described by Chung et al (2013) with some modifications 
(Fig 3.3A,B). On day 1 after perfusion with hydrogel solution, no difference was seen 
between the fixed brain and traditional PFA fixed brain. On hydrogel hybridization 
and polymerization, the brain was embedded in the hydrogel mesh. After 3 days’ 
washing with clearing solution, the appearance of the brain, regarding the color, 
transparency and size, remained similar. Then, the mouse brain was subjected to 
electrophoresis tissue clearing process, during which brain tissue was maintained in 
the ETC chamber and subjected to electrophoresis with clearing solution circulating 
through the ETC chamber (Fig 3.3A,B). 36h after ETC clearing, the brain tissue 
became a bit transparent (Fig 3.3D) compared to pre-clearing. However, the size of 
the brain from top view was augmented from 1.4cm x 1.1cm to 2.3cm x 1.7cm (Fig 
3.3D, H). 48h after ETC clearing, the transparency was significantly increased, and 
the background characters could be seen more clearly (Fig 3.3E). However, besides 
the further increase in volume (2.6cm x 1.8cm), the brain appeared to be more 
yellowish (Fig 3.3E,H). 60h and 72h after ETC clearing, there is minimum change in 
either transparency, the volume or the color of the brain tissue (Fig 3.3 F,H). The 
ETC clearing process was ceased at 72h, because our CLARTY system still needs 
some optimization, which will be discussed later. Hence, the imaging process was not 
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conducted and the molecular characteristics of our CLARITY process were not 
identified. Results showed that with the set up of CLARITY procedures in our lab, 
including hydrogel hybridization and electrophoresis tissue clearing, the mouse brain 
could be transformed into transparent status, which provides the promising evidence 
of progress for further studies using CLARITY. 
 
4. Discussion 
4.1 NI Projection to mPFC / ACC 
Tract tracing studies had revealed the projection from NI to mPFC, and the 
expression of neuromodulators in the NI neurons was partly delineated (Ryan et al., 
2011). However, no report has illustrated specifically the expression profile of NI 
neurons projecting to mPFC. mPFC plays a particularly important role in mediating 
working memory (Homes and Wellman, 2009). But this structure is an area most 
sensitive to stress (Arnsten, 2009). Depending on variations in the nature of stressful 
events, either impairment, or facilitation, or no effect on the mPFC and working 
memory function may result (Sandi and Pinelo-Nava, 2007). For the past decade, 
myriads of studies have focused on the PFC, especially the effects of stress on mPFC 
neuron morphological changes and working memory modulation (Arnsten, 2009). 
The NI has been proved to respond to stress. Intracerebarelventricular CRF infusion 
and swim stress both activate the NI (Ryan et al., 2010). Our group further focused on 
NI-mPFC modulation. Our previous study specifically demonstrated that NI CRF 
infusion activates mPFC neuronal firing, which suggests the participation of the NI in 
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stress responses and the corresponding modulation in mPFC. However, whether the 
stress responsive NI neurons are those directly project to the mPFC, or those 
indirectly project to mPFC through transit stations, needed to be examined. 
 
Therefore, firstly, we investigated the expression of CRF1 in NI-mPFC projection 
neurons. In our retrograde tracing study with FG infusion in the mPFC, almost all the 
NI neurons projecting to the mPFC express CRF1 receptor, indicating the likely 
involvement of these NI-mPFC direct projection neurons in stress responses. 
Moreover, approximately 40% of CRF1 neurons in the NI project to mPFC, which 
suggested the critical innervation of NI to mPFC under stress. No other literature has 
quantified the NI CRF1 neuron involved in innervations of other structures, such as 
hippocampus, amygdala, medial septum, receiving heavy projections from the NI. 
The most interesting comparison would be that, in NI-Septohippocampal projections, 
which plays a crucial role in theta activity modulation, though the expression of 
VGLUT2 in the projection neurons added a glutamate component to the NI-MS/DB 
pathway, statistically, only 30% of the projections were excitatory glutamate neurons 
(Cervera-Ferri et al., 2012). Our results again verify the generally accepted evidence 
of NI response under stress and strengthen our previous finding that the NI directly 
modulates mPFC in response to stress.  
 
Secondly, to further investigate the potential mechanism of NI responses modulating 
mPFC under stress, expression of other neurochemicals in the NI-mPFC projection 
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neurons were examined. The neuropeptide, RLN3, which is suggested to play a 
crucial role in NI functioning, is also highly presented in the NI-mPFC neurons. 
Moreover, though direct evidence of CRF1, RLN3 and FG triple staining is required, 
the percentage implied that almost all NI CRF1 neurons projecting to mPFC were also 
RLN3 positive. Nevertheless, Ma et al. (2013) distinguished the NI neurons into three 
heterogeneous groups of CRF1+/RLN3+, CRF1+/RLN3-, CRF1-/RLN3-, and each 
group of neurons responded differently to CRF and showed different coherent activity 
with hippocampal theta rhythm in the rat. Particularly, out of all NI neurons, only 53% 
of the NI CRF1 population was RLN3 positive (Ma et al., 2013). The difference 
indicates a distinct character of the NI-mPFC projection population in that it belongs 
to the CRF1+/RLN3+ group of NI neurons. Ma also identified that most neurons 
excited by icv CRF infusion were RLN3 positive, whereas all inhibited neurons were 
RLN3 negative (Ma et al., 2013). Together with our results of high CRF1 and RLN3 
colocolization in the NI-mPFC projection neurons, this again indicates that almost all 
NI-mPFC projections are responsive to CRF. On the other hand, the high expression 
of the RLN3 cognate receptor, RXFP3, in mPFC implicated the potential role of 
RLN3 in mPFC modulation (Smith et al., 2011). Since the NI is the primary source of 
RLN3 in the brain, it is likely that NI RLN3 neurons play a role in mPFC modulation.  
 
Regarding the D2S receptor, similarly, almost all NI-mPFC projection neurons express 
D2S, suggesting the potential involvement of D2S receptor in NI-mPFC modulation. 
Since it was our lab that first described the presentation of a D2S positive neuron 
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population in the NI, the anatomy and physiological knowledge of NI D2S neurons is 
limited. D2S is mainly a presynaptic receptor (Rankin et al., 2010). If NI cells 
themselves release dopamine, the high presentation of D2S in the NI-mPFC neurons 
and the activation of this population might lead to decreased dopamine release into 
mPFC and make an impact on mPFC function. We also identified the potential for 
synthesis of dopamine in NI neurons by tyrosine hydroxylase (TH) staining, however, 
the expression is relatively quite low in the NI compared to the nearby locus 
coeruleus. However, it is important to further distinguish the type of mPFC neurons 
that NI-mPFC projections contact with to understand the possible modulation 
mechanism of dopamine modulation via the NI.  
 
The NI-ACC chemoarchitecture was also characterized. The expression patterns of 
CRF1, RLN3 and D2S in NI-ACC projection neurons were all similar to NI-mPFC 
projections, suggesting the involvement of NI in ACC modulation under stress and 
potential role of RLN3 and D2S in NI-ACC regulation. However, the similar 
expression pattern does not necessary mean that the effect of NI on mPFC and ACC 
are similar. It depends on the characteristics of the ACC neurons that NI-ACC 
neurons project to. Despite similar expression of the three neuromodulators, the 
NI-ACC connections were significantly less abundant than NI-mPFC projection 
neurons. However, there are some discrepancies in the NI-mPFC/ACC projections. 
Previously, only one group compared NI-ACC and NI-mPFC projections by 
retrograde studies from ACC and mPFC respectively. In their report, moderate 
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NI-ACC connections and light NI-mPFC connection were observed (Hoover and 
Vertes, 2007). In our study, both NI-mPFC and NI-ACC connections were revealed, 
and NI had less innervation in ACC than in mPFC.  
 
However, there are some limitations in our study, which might be overcome by 
advanced methods. First, the FG labeling in NI from ACC retrograde tracing was 
much lighter than from mPFC tracing. It might be caused by our tracer injection 
method. We used 1μl Hamilton syringe for injection, and the tissue damage was 
relatively large. Since ACC locates near the surface of the brain, the injected FG 
might be diffused away into cerebrospinal fluid through the damage tract. Therefore, 
iontophoretic injection might be a better choice, since it is more accurate and causes 
less damage (Hoover and Vertes, 2007). Secondly, the FG is light sensitive. 
Photobleaching of FG labeling was observed during imaging, especially in confocal 
imaging requiring long term laser exposure. Further retrograde tracing studies with 
FG will use anti-fluorogold antibody to stain for the FG labeled neurons, which will 
assure a longer preservation of the fluoroscence signal. Thirdly, the best excitation of 
FG is at 325nm, and the maximum excitation wavelength is 414nm (Catapano et al., 
2008). Usually, a microscope with an ultraviolet filter is required. However, in our 
study, a 408nm confocal laser line was used to excite FG, which might lead to lower 
emission. A confocal microscope equipped for ultraviolet wavelengths would enable 
more accurate and better confocal imaging for FG. However, these limitations would 
not have effects on the quantitative result of the neuromodulator expression in 
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NI-mPFC/ACC projections. 
 
Part of the chemoarchitecture of NI-mPFC/ACC projections, including the expression 
of CRF1, RLN3 and D2S, was demonstrated in this study. Further study will focus on 
two aspects. First, vertically, a more profound understanding about the mechanism 
and the effects of the three modulators in the NI on mPFC function modulation will 
be investigated. The following studies described in the later chapters have progressed 
knowledge of the role of CRF1 in mPFC modulation. For RLN3 and D2S, our 
established model of in vivo electrophysiology of HP-mPFC LTP induction in the rat 
and behavioral models regarding mPFC function, would be intensively used to reveal 
the physiological involvement the neurochemicals, again, it will be describe in detail 
in the later chapters. Moreover, the type of mPFC neurons that NI-mPFC projections 
contact with will be examined. mPFC has a complex network of excitatory pyramidal 
neurons and inhibitory interneurons (Khan et al., 2011). Whether they synapse onto 
pyramidal neurons or interneurons in the mPFC may determine innate function of NI 
in mPFC modulation. Therefore, anterograde tracing from NI will be applied, 
together with triple staining of the marker proteins for pyramidal neurons 
(non-phosphorylated neurofilament) and interneurons (calbindin, parvalbumin) 
(Henny and Jones, 2008), as well as RLN3, the projection type could be recognized. 
Secondly, horizontally, the chemoarchitecture of NI projections to other cognition 
related brain regions, such as hippocampal formation and amygdala, will be further 
characterized. In addition, although no specific distribution of NI-mPFC or NI-ACC 
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projections was observed, it is still interesting and of great importance to understand 
whether those projecting to mPFC and ACC are the same NI neurons or different to 
reveal the function and correlation of mPFC and ACC under stress. Double tracing or 
CLARITY, which will be elucidated later, would be used to identify this issue.  
 
4.2 Establishment of CLARITY 
To study the NI connections throughout the brain more accurately and systematically, 
we tried to establish the CLARITY method in our lab. The steps established 
encompass: (1) Perfusion with hydrogel solution, (2) Degassing, (3) Hydrogel tissue 
embedding, (4) Washing with clearing solution, and (5) Electrophoretic tissue 
clearing (ETC). Our results showed that during the ETC process, the whole mouse 
brain became more and more transparent. A significant change in transparency was 
observed from 36h to 48h of ETC, while less progress was seen from 48h to 72h ETC. 
These results revealed the effectiveness of our established CLARITY system to 
actively extract the lipids, make the brain tissue transparent and better for imaging. 
However, some problems occurred during our CLARITY process, hence we 
discontinued the experiment after 72h of ETC. As a result, comparing to Chung et 
al.’s (2013) outcome of 8 days’ ETC clearing, the transparency of our brain was not 
equivalent. It might be caused by insufficient clearing time and/or not immersing the 
brain into an RI specified solution matching the CLARITY hybrid, such as Focus 
Clear, during imaging. Three main technical problems were encountered. Firstly, no 
appropriate cooling water circulator was available to stabilize the temperature of the 
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circulating clearing solution. Since the electrophoretic process continuously produces 
a large amount of heat, a cooling water circulator is required. In our system, we 
stabilized the temperature by embedding the clearing solution into ice while 
circulating the solution with a normal water bath circulator. However, although the 
temperature could be stabilized in this way, the ice was continuously melting, thus 
the ice needed to be changed about every half day. Therefore, overnight ETC was not 
feasible, which caused an extended tissue clearing time. In this case, an availability of 
a cooling water circulator might be necessary. Secondly, the ETC brain was 
yellowish. Recently, a member of our laboratory attended the CLARITY workshop 
held by Deisseroth’s lab in Stanford University. They are also faced with this 
problem. It is still caused by the heat generated from the electrodes during the ETC 
process. The optimization in the electrophoresis voltage and controlled temperature of 
the clearing solution would be helpful. We used 40V and 40℃. Despite Deisseroth’s 
suggestion of 20V and 37℃, optimization is still required in our system. In addition, 
a powerful pump fast circulating the clearing solution at the speed of minimum 
1L/min would help to diffuse the heat. Thirdly, there was a severe swelling of the 
brain tissue after the ETC process. According to the suggestion, immersion into Focus 
Clear would restore the brain to the original size. In summary, a cooling water 
circulator, an efficient pump and a lower voltage during ETC would improve our 
CLARITY system. 
 
There are good prospects for application of CLARITY in future development of our 
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research. Besides these optimizations, we would continue trying with imaging 
process after a fair transparency of the brain is achieved. We would first image with 
traditional confocal microscopy. To solve the problem of long exposure time related 
photobleaching during imaging, we would collaborate to develop the use of light field 
camera for imaging the clarified brain. On the establishment of the whole CLARITY 
process both in mouse and rat, we would carry on with our study of NI connections. 
First, for NI mapping, anterograde and retrograde tracing from NI would be applied, 
followed by CLARITY clearing and imaging to reconstruct the NI outputs and inputs 
throughout the brain. Second, we would focus specifically on the projection of NI to 
mPFC and ACC, and to determine whether same or different NI neurons project to 
mPFC and ACC. Moreover, combining with the immunostaining methods, the 
chemoarchitecture of the NI projections, especially RLN3 could be further mapped. 
CLARITY is a powerful technique for bulk tissue imaging, thus the establishment of 
CLARITY in our lab would not only serve for this project of NI and cognition, but 
also invaluable to other on-going projects in the lab, for example, the study of the role 
of the NI in anxiety, investigation of hippocampal neurogenesis and studies of 
Alzheimer's disease. The profound investigation of NI connections and 
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Chapter 4  




Stressors are defined as the exogenous or endogenous challenges that threaten 
homeostasis (Selye, 1936). In experimental stress research, stress paradigms are 
divided into two main categories, physiological stressors and psychological stressors. 
Physiological stressors refer to the homeostatic, systemic or physical stressors, 
including osmotic, metabolic, cardiovascular and immune stressors. Psychological 
stressors refer to neurogenic, emotional, or processive stimuli, initiated by complex 
somatosensory and nociceptive systems, and processed via higher order brain 
networks involving emotional and cognitive components, eg. novel environment 
exposure, restraint and footshock. According to the duration and frequency of 
stressful events, stressors could be categorized as acute stress, repeated stress and 
chronic stress (Krisztina et al., 2005). In this project, we focus mainly on acute 
stressors, which refer to a single exposure to single stimuli for a short term.  
 
Widely used acute stressors include forced swim, restraint, footshock, elevation stress 
and predator exposure. In this project, the functions of NI and mPFC are focused on, 
and the most recent evidence for these structures relates to swim stress and elevation 
stress. Exposure of rats to repeated forced swim stress (10min, 24h apart) 
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significantly increased c-Fos and RLN3 mRNA levels after the second exposure, 
suggesting the activation of NI under swim stress (Banarjee et al., 2010). Thirty min 
forced swim stress and 30 min placement on an elevated platform prolonged the 
serotonergic regulation of GABA transmission in mPFC pyramidal neurons, which 
implied the possible mechanism for stress-induced exacerbation of psychiatric 
disorders (Tan et al., 2004). Moreover, 30 min elevation stress markedly impaired 
HP-mPFC LTP induction (Rocher et al., 2004; Mailliet et al., 2008; Qi et al., 2009). 
Thus swim stress and elevation stress would be potentially suitable stress models for 
our study. In addition, water temperature is an important determinant of stress 
intensity and the corresponding neurochemical and behavioral responses in swim 
stress (Linthorst, et al., 2008), the stress models of 30 min swim, cold swim 20 min, 
10-10 min swim and elevation stress were tested in this study.  
 
1.2 Stress and c-Fos expression 
Immediate early genes are genes rapidly and transiently expressed upon receiving a 
variety of stimuli, hence, are usually used as markers for neuronal activation. Among 
them, c-Fos has been most widely used to determine neuronal activity and circuitries 
in response to stressful events. Under normal physiological condition, the basal 
expression of c-Fos is very low or absent in most brain regions, whereas with stress 
stimuli, c-Fos is rapidly and robustly expressed (Martinez et al., 2002). The 
transcription of c-Fos mRNA and its protein product Fos could be easily identified 
and quantified showing the pattern of activated neurons. However, the induction of 
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c-Fos is transient, so the timing of the analysis is important. Generally, c-Fos mRNA 
transcription shows maxium upregulation 30 min after stress, and is diminished 1h 
poststress. Fos immunoreactivity is revealed 15-30min after rapid stress, shows 
maximum at 90-180min poststress and decline thereafter (Krisztina et al., 2005).  
In the NI, several studies have also identified the expression of c-Fos under stress. 
The basal expression of c-Fos mRNA in the NI is minimal (Cullinan et al., 1995). 
However, with intracerebroventricular CRF administration, Fos immunoreactivity (IR) 
was significantly increased 2h after treatment (Tanaka et al., 2005). Other acute 
psychological or neurogenic stressors, including forced swim stress, restraint stress, 
foot shock and noxious stimuli were also seen to induce c-Fos mRNA or Fos 
expression, whereas systemic or physiological based stressors didn’t appear to 
activate the NI (Ryan et al., 2011). 
1.3 Stress and corticosterone level 
Corticosterone is a type of glucocorticoid released in rodents. In response to stress, 
the HPA system initiates the secretion of corticosterone into the blood from adrenal 
cortex (Fuchs et al., 2006). Corticosterone binds to mineralocorticoid receptors (MR) 
or glucocorticoid receptors (GR), and modulates gene transcription and cell electrical 
activity via intracellular signaling pathways, consequently, results in physiological 
and psychological changes to alert the organisms of the stress, as well as to restore 
homeostasis (Kloet et al., 1990; Joëls et al., 2012). An excessive, prolonged or 
inadequate corticosterone response that impairs adaptation to stress is considered a 
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risk factor for psyciatric disorders (Joëls et al., 2012). Therefore, serum corticosterone 
concentration is associated with stress intensity and has been extensively used as a 
physiological indicator to validate the impact of stress. The corticosterone level also 
varies in a time course post-stress. On exposure to a stressor (15 min swim stress), 
corticosterone levels rise rapidly, while negative feedback normalizing corticosterone 
levels also begins. The corticosterone level reaches the maximum by the end of stress, 
and then constantly decreases. One hour after stress, the corticosterone level returns 
to about half of the maximum. By three hours post-stress, the corticosterone is almost 
restored to normal levels (Koolhaas et al., 2011; Kloet et al., 2007). 
 
1.4 Stress and Hippocampal-medial Prefrontal Cortical Pathway 
Hippocampal-medial prefrontal cortical pathway (HP-mPFC) refers to a 
monosynaptic unidirectional projection between the two regions (Ongur and Price, 
2000). In rats, the HP-mPFC pathway originates from the CA1 and subiculum region 
of the hippocampal formation. The fibers extend ipsilaterally to the fimbria/fornix 
area, and terminate in the infralimbic (IL) and prelimibic (PL) sub-regions of the 
medial prefrontal cortex (Cenquizca and Swanson, 2007; Hoover and Vertes, 2007). 
The pathway consists of excitatory glutamatergic pyramidal neurons that synapse on 
to both principle neurons and GABAergic interneurons in the mPFC (Carr and Sesack, 
1996; Tierney et al., 2004). Synaptic plasticity of long-term potentiation (LTP) and 
long-term depression (LTD) is an important characteristic of the HP-mPFC pathway 
(Burette et al., 1997; Takita et al., 1999). Glutamergic transmission is a key regulator 
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of LTP in the pathway. NMDA-receptor blockade and PKA blockade prevented LTP 
(Jay et al., 1995; Gurden et al., 2000). The dopaminergic system also plays a key role 
in the regulation of HP-mPFC plastisity, especially mediated by dopamine D1 
receptors (Gurden et al., 2000). Besides, serotonergic, noradrenergic, and cholinergic 
neurotransmitter systems are involved as well (Lim et al., 2010; Wang and Yuan, 
2009; Ohashi et al., 2003). 
 
The HP-mPFC pathway participates in various cognitive functions, including 
working memory, learning and contextual processing to serve memory and emotional 
regulation. The interaction and coordination of HP and mPFC in working memory 
function are proved by three lines of evidence: 1. With asymmetric pathway 
disconnection methods in which HP-mPFC pathways are compromised bilaterally 
(the hippocampal formation was disrupted in one hemisphere and the PFC in the 
other), studies revealed that the HP-mPFC pathway is largely ipsilateral and the 
simultaneous function of the two structures within the same hemisphere is necessary 
for working memory performance (Floresco et al., 1997); 2. In the win-shift radial 
arm maze task, disconnection of HP and mPFC disrupted performance in the delayed 
condition but not in the non-delayed condition, which strongly suggests the 
interaction of HP and mPFC in working memory requiring the short-term storage of 
information (Floresco et al., 1997); 3. Synchronous activity of HP and mPFC with a 
delay in mPFC neurons during spatial working memory and phase-locking behavior 
tasks also indicates the transfer of information from HP to mPFC (Benchenane et al, 
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2010; Fujisawa and Buzsaki, 2011). In particular, the underlying mechanism might 
depend on: (1) Interneuron-mediated inhibition of pyramidal neurons in the mPFC 
(Sotres-Bayon et al., 2012); (2) Entrainment of mPFC neurons to hippocampal theta 
(Benchenane et al., 2010); (3) Synaptic plasticity of the HP-mPFC pathway (Jay et al., 
1995). 
 
The HP-mPFC pathway is sensitive to stress. Exposure to stress lead to short and 
long term changes in the hippocampal formation and mPFC depending on the 
intensity and duration of stress (Godsil et al., 2013). Single exposures to mild or 
moderate stressors modulate synaptic plasticity and memory performance (Rocher et 
al., 2004; Yuen et al., 2009), while exposures to more intensive or chronic stressors 
induce dendritic remodeling, neuron atrophy (Pittenger and Duman, 2008; Cerqueira 
et al., 2007a). Acute behavioral stress on an elevated platform has been shown to 
disrupt the induction of HP-mPFC LTP in vivo in anesthetized rats, and the effect 
was reversed by antidepressants (Rocher et al., 2004), hence it has been used as a 
model to simulate psychiatric disorders and to the discovery of drugs to treat 
stress-related disorders. More detailed studies revealed that acute exposure to an 
elevated platform trigger the changes in the phosphorylation of glutamatergic 
receptors, as well as down-regulation of the MEK/MAPK signaling and BDNF levels 
(Caudal et al., 2010; Qi et al., 2009). Therefore, in this study, we would like to 
determine whether the NI plays a role in HP-mPFC plastisity modulation under stress, 
and acute exposure to elevated platform stress together with swim stress models were 
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examined here. 
 
1.5 CRF1 antagonist – antalarmin 
Antalarmin has been widely used as a selective CRF1 receptor antagonist. Antalarmin 
is a pyrrolopyrimidine compound first synthesized in 1994. It specifically blocks 
CRF1 receptor and consequently suppresses the release of pituitary ACTH (Webster 
et al., 1996). Antalarmin also reduces the behavioral response to stressful stimuli 
(Fahmy et al., 2012). The induction and expression of conditioned fear are both 
impaired by antalarmin treatment (Deak et al., 1999). Pretreatment with antalarmin 
attenuated the stress-like behaviors, including burying, grooming, and head-shakes, 
elicited by central CRF administration (Howard et al., 2008). Antalarmin has also 
been applied to the NI study. Exposure of rats to repeated forced swim stress 
significantly increased RLN3 mRNA and hnRNA levels in the NI after the second 
swim, whereas systemic antalarmin administration 30 min prior to the second swim 
reversed the stress-induced effects on RLN3 transcripts (Banerjee et al., 2010). Based 
on this evidence, antalarmin is also applied here in this project as a selective CRF1 
receptor antagonist to specifically block the CRF effects in the NI. 
 
In this chapter, the role the of NI in the HP-mPFC pathway in response to stressors is 
examined. Therefore, we first selected appropriate stress models, which impair 
HP-mPFC LTP and induce corresponding NI activation (Fos-IR induction after stress) 
and corticosterone response. After that, with acute exposure to the stressor, the effects 
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of intra-NI CRF1 antagonist treatment on HP-mPFC LTP were determined. 
 
2. Materials and Methods 
2.1 Stress paradigms 
Adult male SD rats (290-350g) were habituated 2-3 days in standard housing 
conditions before experiments. Four stress paradigms were conducted here. Generally, 
there were two categories, swim stress and elevation stress. In swim stress, rats were 
forced to swim in a plastic bucket (32cm D x 42cm H) filled with 30cm water (Fig 
4.1A). There were three variations in swim stress. (1) 30 min swim. The rats were 
forced to swim for 30 min in room temperature 24-25°C water. (2) 10-10 min swim. 
The rats were subjected to swim for 10 min and returned to housing. 24h later, the 10 
min  swim stress was repeated. (3) Cold swim 20 min. The rats were exposed to 20 
min swim in cold 18°C water. After   swim stress, the rats were dried with a towel. In 
elevation stress, the rats were placed on an unsteady elevated platform (20cm x 20cm, 
1m above ground) for 30 min with two powerful lamps (90cm apart) focusing on the 
rats (Fig 4.1B). Non-stress control rats were kept in their home cages for 30 min 
before subsequent procedures. 
 
2.2 Immunochemistry and cell counting 
To study c-Fos expression, the rats were further kept in home cages for 2h after stress 
before sacrifice and transcardially perfusion. After similar tissue processing to that 
described in Chapter 3, 6-8 serial sections (40μm) of NI per brain were blocked with 
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goat serum and incubated with anti-c-Fos primary antibody (PC38, Calbiochem, 
Merck) overnight at 4°C. The sections were then incubated with secondary antibody 
Alexa Fluor 555 goat anti-rabbit (1:200; Invitrogen) and mounted with ProLong Gold 
Antifade reagent with DAPI (P36935, Molecular Probes, Invitrogen). The c-Fos 
immunoreactivity was imaged with a fluorescence microscope. The numbers of c-Fos 
positive NI neurons were counted after merging with DAPI stained images of the 
same section for 6-8 sections per brain. The values were represented by the number of 
c-Fos postive NI neurons divided by the total area of NI.  
 
2.3 Corticosterone ELISA Assay 
To study corticosterone levels, the rats were anesthetized with intraperitoneal 
injection of chloral hydrate (400 mg/kg, Sigma-Aldrich, MO, USA) immediately 
after stress. The blood was collected immediately from the tail by tail-vein 
cannulation. The collected blood was centrifuged at 3000rpm x 15 min, then the 
serum was collected and kept in -20°C until corticosterone assay. The serum 
corticosterone level was evaluated by Corticosterone ELISA kit (108821, Abcam) 
following the product protocol. 
2.4 Evoked field potential recording 
After blood collection, the rats were prepared for evoked field potential recording 
(Farooq et al., 2013). Briefly, with similar surgery procedures to those described in 
Chapter 3, a monopolar electrode (SNE-300; Kopf Instruments) was lowered into the 
mPFC (AP 3.3mm, ML 0.8mm), and a bipolar electrode was lowered into the 
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ipsilateral CA1/ventral subiculum of the hippocampal formation (AP -6.3mm, ML 
5.5mm). To place the electrodes in the proper HP-mPFC pathway, a test stimulus 
(250-350 μA) was applied to the hippocampal formation every 15 s and the electrode 
positions were adjusted to maximize the amplitude of negative-going wave of the 
field excitatory post-synaptic potential (fEPSP). Once the maximal fEPSP was 
localized, the electrodes were left in place for 10 min for stabilization. After that, to 
set the stimulus intensity used for LTP experiment, an input–output curve (IOC; 
100-450μA) for the evoked response was constructed and the stimulus intensity was 
set at 60% of the maximum fEPSP. Test stimulation of the hippocampal formation 
was applied every 30 s during the stabilization and the IOC period. Later, the LTP 
experiment protocol consisted three stages. It started with a 30 min baseline recording, 
followed by ten trains of high-frequency stimulation (HFS; 50 pulses, 250 Hz) with 
inter-train interval of 10 s, and finally 90 min of post-HFS recording. The test 
stimulation was also applied every 30s during the baseline and post-HFS recording. 
For analysis, the averaged fEPSPs for 5 min were expressed as mean percentage ± 
sem normalized against the baseline in each group. The 5 groups were 30 min swim, 
10-10 min swim, cold swim 20 min, elevation stress and non-stress (n=4, 4, 5, 8, 5 
respectively). 
 
2.5 Cannula implantation and drug treatments 
After establishment of effective stress protocol, the role of NI in HP-mPFC LTP 
under stress was investigated. Two groups of rats were treated with antalarmin 
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(Antalarmin hydrochloride, 2778, Tocris). Antalarmin was dissolved in sterile saline 
at 65℃ and cooled (Banerjee et al., 2010). After similar surgery procedures to those 
described above, a guide cannula was implanted targeting the NI (AP -9.7mm, DV 
-7.4mm). A dummy cannula was inserted and kept until drug infusion. The rats were 
rehabilitated for at least 1 week before following experiments. Both groups were 
subjected to elevation stress, followed by evoked field potential recording of 
HP-mPFC LTP. Among them, one group of rats was infused with 0.25μg antalarmin 
in 0.1μl 10 min before elevation stress, while the other group was infused with 
0.25μg antalarmin 5 min before high frequency stimulation during evoked field 
potential recording. An infusion cannula attached to a 1μl Hamilton syringe 
connected by an infusion tube was used for drug administration. After 
electrophysiology test, the rats were perfused and the brains were harvested to check 
the NI cannulation position. Only rats with correct NI cannula positions were 
included in the data analysis.  
 
3.  Results 
3.1 Effects of stressors on NI activation 
Based on the aforementioned neuroanatomical evidence that NI-mPFC projection 
neurons express CRF1 and the electrophysiological evidence that NI stimulation and 
intra-NI CRF activated NI and suppressed the induction of HP-mPFC LTP, the role 
of NI in stress-induced mPFC modulation is strongly suggested. However, these two 
situations were just a mimic of stress. Therefore, in this chapter, the rats were  
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Figure 4.1 Effects of stress protocols on NI c-Fos expression and corticosterone level. (A)(B) Schematic 
models of swim and elevation stress protocols. (C) Representative images of NI c-Fos expression 2h after non-stress, 
30 min swim, cold swim 20 min and Elevation stress respectively. (D) Average number of c-Fos positive neurons per 
mm2 NI, exposed to stress protocols compare to non-stress, showing stress protocols significantly increased NI c-Fos 
expression. (E) Corticosterone concentration in serum exposed to stress protocols compare to non-stress, showing 30 
min and cold swim 20 min stress significantly increased corticosterone levels. Values are represented as mean±sem. 
Scale bars = 100 μm. **P<0.01, ***P<0.001. 
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exposed to “real stress conditions”. Namely, the physiological involvement of NI in 
stressors-induced mPFC modulation, particularly HP-mPFC pathway regulation, was 
examined and described. To understand the role of NI in the process, an optimal  
stress paradigm, which impairs HP-mPFC LTP and correspondingly activate NI 
neuronal firing and corticosterone response, should be established first. Four stress 
protocols were compared, comprising 30 min swim, cold swim 20 min, 10-10 min 
repeated swim and elevation stress. 
 
The degree of NI activation and neuronal firing was represented by the c-Fos 
expression. In this study, the level of Fos-IR induction in the NI after stress was 
determined and compared between different stress models. The rats were exposed to 
the stress protocols and sacrificed 2h after acute stress, then stained for c-Fos. Results 
indicated that 2h after stress exposure, induction in Fos IR and NI activation were 
observed in all stress protocols examined, including 30 min swim, cold swim 20 min 
and elevation stress, as compared to non-stress group (Fig4.1C). The numbers of Fos 
IR NI neurons were quantified in detail. For statistical analysis, since different 
stressors were tested in different days together with a corresponding non-stress group, 
in order to compare between different stressors, one-way ANOVA was used to test the 
homogeneity of control groups. There was no significant difference in numbers of 
c-Fos positive NI neurons between non-stress groups, hence all the non-stress rats 
were combined as one control group. Comparing all four groups, again, one-way 
ANOVA revealed the significant [F(3,23)=102.715, p<0.0001] difference between 30 
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min swim, cold swim 20 min, elevation stress and non-stress groups (Fig 4.1D; 
n=4,4,4,12). Bonferonni posthoc test showed that all stressors significantly (p<0.0001) 
increased c-Fos levels. Comparing different stressors, there was no significant 
difference in Fos-IR expression between them, but a trend of higher c-Fos expression 
could be seen in the elevation stress group (Fig 4.1D). These results elucidated that 
all stress paradigms tested could trigger the activation of NI neurons, among them 
elevation stress has a slightly stronger effect. 
 
3.2 Effects of stressors on corticosterone level 
Corticosterone level is widely regarded as a physiological indicator of stress. For the 
study of corticosterone levels, again, the rats were subjected to 30 min swim, cold 
swim 20min, 10-10 min swim or non-stress (n=3, 8, 3, 3) and the serum was collected 
immediately after stress and tested with corticosterone ELISA assay. One way 
ANOVA illustrated that stress protocols significantly [F(3,16)=6.535, p<0.01] affect 
the corticosterone levels. 30 min swim stress and cold swim 20 min both significantly 
increased corticosterone level (Fig 4.1E, p<0.05, p<0.01 respectively). However, 
10-10 min repeated swim stress had no significant effect in corticosterone response. 
The results again indicate the high stress intensity of 30 min swim and cold swim 20 
min stress. 
 
3.3 Effects of stressors on HP-mPFC LTP 
On top of the effects on NI activation and corticosterone response, the most important  
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Figure 4.2 Effects of stress protocols on HP-mPFC LTP. (A)-(E) Data points represent 5 min average 
of normalized fEPSP comparing stress and non-stress. (A)-(D) showing 30 min swim, Cold swim 20 min, 
Elevation stress, and 10-10 min swim respectively. (E) Combined comparison of all stress and non-stress 
groups. (F)-(I) Columns represent 30 min average of normalized fEPSP comparing stress and non-stress. 
30 min swim, cold swim 20 min and Elevation stress significantly suppressed HP-mPFC LTP. (J) 
Representative fEPSP waveforms at the mPFC following hippocampal formation stimulation. Grey line: 
baseline; Black line: post HFS; Dotted line: post HFS subjected to elevation stress; Scale bar = 10 ms, 0.1 
mV. fEPSP is represented by mean±sem. ***P<0.001. 
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criteria to determine the optimal stress model is the effects of the stress models on 
HP-mPFC pathway. To investigate the effects of stress protocols on HP-mPFC LTP 
induction, similarly, the rats were first exposed to a particular acute stress, then 
immediately anaesthetized and subjected to in vivo electrophysiology recording of 
evoked field potential. For HP-mPFC pathway recording, the hippocampal formation 
was constantly stimulated and the field evoked postsynaptic potentials (fEPSP) were 
recorded from the mPFC area. The LTP induction was introduced by trains of 
high-frequency stimulation (HFS) in the hippocampal region. Five groups were 
examined, including 30 min swim, cold swim 20 min, 10-10 min repeated swim, 
elevation stress and non-stress (n=6,6,4,7,6).  
 
Stimulation of the HP resulted in a characteristic negative going waveform with a 
latency of 18-26 ms (Fig 4.2J). In normal condition, HFS of the HP induced an LTP 
(Fig 4.2A). Repeated-measures ANOVA indicated that within subject effects were 
significant [F(24,120)=11.546, p<0.0001], and the amplitude of fEPSP post HFS at 
all the time points were significantly increased compared to baseline.  
 
Upon stress exposure, impairment in LTP was observed in most of the stress 
protocols tested. Repeated-measures ANOVA of between subject effects showed that 
stressors significantly [F(4,24)=6.726, p<0.001] affected the HP-mPFC LTP (Fig 4.2 
A-E). Among them, 30 min swim, cold swim 20 min and elevation stress all 
significantly [F(1,24)=13.961, p=0.0010; F(1,24)=7.1473, p=0.0133; 
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F(1,24)=18.3365, p=0.0003] suppressed LTP induction compared to non-stress (Fig 
4.2A-C). Compare the three stress protocols, cold swim 20 min has less significant 
level in LTP suppression. Two-tail Student’s t-test comparisons again showed that 30 
min swim, cold swim 20 min and elevation stress significantly (p<0.0001) reduced 
the fEPSP at all time points post HFS (T1-30min, T31-60min, T61-90min, Fig 4.2F-H). However, 
10-10 min repeated swim stress had no significant [F(1,24)=0.2169, p=0.6456] effect 
on HP-mPFC LTP (Fig 4.2 D, I). Combining all groups together, it is more obvious 
that 30 min swim, cold swim 20 min and elevation stress suppressed HP-mPFC LTP 
(Fig 4.2E). In the representative fEPSPs, comparing the post HFS fEPSP of the 
non-stress group and the post HFS fEPSP of the stress group, here elevation stress, 
there was a decrease in the amplitude in the stress group (Fig 4.2 J).  
 
All in all, taking the effects of stress paradigms on NI activation, corticosterone level 
and HP-mPFC LTP into consideration, 30 min swim and elevation stress are suitable 
for further study of the NI involvement in stressor-induced HP-mPFC impairment. 
Thus at this stage, the proper stress models for further studies were established. 
 
3.4 Role of NI in stressor-induced HP-mPFC LTP modulation 
After the establishment of optimal stress models, we carried on to study the role of NI 
in mPFC modulation in response to stressors via investigating the effects of intra-NI 
CRF1 antagonist – antalarmin infusion. Specifically, whether intra-NI infusion of 
CRF1 antagonist could block and reverse the effects of stress-induced suppression of  





Figure 4.3 Role of NI in stressor-induced HP-mPFC LTP modulation. (A)-(C) Data points 
represent 5 min average of normalized fEPSP comparing stress and non-stress. (A)(B) showing 
pre-elevation stress antalarmin treatment and pre-HFS antalarmin treatment groups respectively. (C) 
Combined comparison of elevation stress, two antalarmin treatment and non-stress groups. (D)-(F) 
Columns represent 30 min average of normalized fEPSP comparing antalarmin treatment, elevation stress 
and non-stress groups. Both pre-elevation stress antalarmin treatment and pre-HFS antalarmin treatment 
significantly blocked the suppression of HP-mPFC LTP caused by elevation stress. fEPSP is represented 
by mean±sem. ***P<0.001. 
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HP-mPFC LTP induction.  
 
The stress paradigm of elevation stress was applied here. Both groups were exposed 
to elevation stress followed by in vivo evoked field potential recording. However, one 
group of rats received an antalarmin dose 10 min before elevation stress (Before 
stress; n=5) and the other group was infused 5 min before HFS (Before HFS; n=4). 
The effects of antalarmin infusion at these two different infusion time points were 
compared. The results indicated an increase in the post HFS fEPSP amplitude in both 
treatments (Fig 4.3 A, B). Repeated-measures ANOVA of (1) antalarmin before stress, 
(2) antalarmin before HFS and (3) elevation stress alone without antalarmin treatment 
groups revealed that antalarmin treatment significantly [F(2,13)=4.5843, p=0.0311] 
influenced the induction of HP-mPFC LTP. Both before stress [F(1,13)=6.5988, 
p=0.0233] and before HFS [F(1,13)=6.1332, p=0.0278] treatment groups 
significantly blocked the suppression of HP-mPFC LTP caused by elevation stress. 
Similarly, two-tail Student’s t-test comparisons also indicated that both treatment 
groups significantly (p<0.0001) reduced the fEPSP at all time points post HFS (Fig 
4.3 D,E). However, the blockade was not complete. Although there was no significant 
difference, the LTP in the antalarmin treatment groups was not as strong as that in the 
non-stress group (Fig 4.3 A,B). This incomplete blockade of HP-mPFC LTP 
impairment by elevation stress, might because other structures are also responding to 
the stress and suppress LTP. Further study is required to top up the numbers, set 
proper control groups and test with different antalarmin doses.   
	   57	  
4. Discussion 
4.1 Establishment of Stress Model 
Based on the previous electrophysiology evidence and the neuroanatomical evidence 
mentioned in Chapter 3, both NI electrical stimulation and intra-NI CRF infusion 
could activate NI, and the activation of NI may directly control mPFC function, 
inhibiting mPFC neuronal firing and suppressing HP-mPFC LTP. However, NI 
electrical stimulation and intra-NI CRF infusion were just a mimic of stress situation. 
Hence, in this chapter, we demonstrated whether the real stress condition of acute 
stressors could activate NI and lead to mPFC modulation. Specifically, the effects of 
NI on the HP-mPFC pathway in response to acute stressors was examined. To verify 
this hypothesis, suitable stress models that could result in the suppression of 
HP-mPFC LTP induction and NI activation were first established.  
 
The stress models of forced swim stress and elevation stress, particularly, 30 min 
swim, cold swim 20 min, 10-10 min swim and 30min elevation stress were examined 
and their effects on NI activation, corticosterone level and HP-mPFC LTP were 
compared. Results showed consistent NI activation and corticosterone level elevation 
of the stress models, with lower stress intensity on 10-10min repeated swim stress 
and a trend of higher stress intensity on elevation stress. Regarding the effects on 
HP-mPFC LTP, 30 min swim, cold swim 20 min and elevation stress significantly 
suppressed the induction of HP-mPFC LTP, whereas 10-10 min swim had no 
significant effect, which was corresponding to the lower stress intensity shown by the 
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serum corticosterone level. Comparing the three effective stress models, elevation 
stress and 30 min swim had a trend towards more severe suppression in LTP.  
 
Our result is in consistent with the evidence that 30 min swim stress and 30 min 
elevation stress both prolonged GABA transmission in mPFC pyramidal neurons, 
suggesting stress-induced mPFC neuron inhibition (Tan et al., 2004). The impairment 
of HP-mPFC LTP by elevation stress was also repeated in our study (Rocher et al., 
2004). However, although 10-10 min swim stress activates NI (Banarjee et al., 2010), 
the induction of HP-mPFC LTP was not impaired in our investigation. Moreover, our 
hypothesis that the high stress intensity of cold swim might lead to a more severe 
impairment in HP-mPFC LTP was also invalid. According to Goto’s view, the NI is 
activated when active behavior is required to escape from the situation (Goto et al., 
2001). This might explain the results of the varied effects of swim stress. Regarding 
the behavioral response during stress, similar to others reports (Linthorst et al., 2008; 
Tan et al., 2004), in 30 min swim stress of 24℃ water temperature, the rats first 
vigorously climb and dive trying to escape, followed by a less active floating and 
sometimes swimming phase, and finally a continually swimming phase again. For 
cold swim 20 min, similar to 30 min swim, a vigorous climbing phase was first 
observed, then transited into a second floating phase, however, with much intensive 
and frequent climbing and swimming in between, maybe attempting to compensate 
for the drop in body temperature. However, in the last phase, instead of vigorous 
swimming, the rats tended to freeze in the water, with a repeated sink and climb up 
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behaviors. The more active second phase and less active third phase might account 
for the reduced significance of cold swim 20 min in HP-mPFC LTP suppression 
compared to 30 min swim. For 10-10min swim, in the second swim, the first phase of 
vigorous climbing was very short, while the rats were mainly floating in the water. 
The less active escaping behavior might be the cause of no significant effect on 
HP-mPFC LTP. In elevation stress, a brief exploring phase, followed by a behavioral 
freezing period was observed, after that, the rats alternated between moving around 
and immobile. However, comparing to 30 min swim stress, less active behavior was 
involved in elevation stress, whereas the NI activation and the suppression in 
HP-mPFC LTP were also highly significant. It might be caused by the innate 
difference in mechanisms of cognitive impairment as a result of the two types of 
stressors.  
 
According to the aforementioned evidence, elevation stress and 30 min swim are 
effective stress models for the following study of the role of NI in mPFC modulation 
in response to stressors.   
 
4.2 Role of NI in stressor-induced HP-mPFC LTP modulation 
Upon establishment of optimal stress models, the investigation of the role of NI in 
stressor induced HP-mPFC LTP modulation was conducted using the elevation stress. 
Results revealed that intra-NI CRF1 antagonist infusion could block the suppression 
effect in HP-mPFC LTP caused by elevation stress. Interestingly, both antagonist  








Figure 4.4 Potential mechanism of role of NI in stressor-induced HP-mPFC LTP modulation 
(A) Mechanism of elevation stress and HP-mPFC LTP suppression. (B) Mechanism of intra-NI CRF1 
antagonist injection before elevation stress and HP-mPFC LTP induction. (C) Mechanism of intra-NI 
CRF1 antagonist injection before HFS and HP-mPFC LTP induction.  
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infusion before elevation stress, or after elevation stress and just before HFS of 
electrophysiology, could reverse the stress effect and trigger the HP-mPFC LTP 
induction. Based on these results, the potential mechanism of stressor-induced NI 
modulation of mPFC could be hypothesized. On exposure to elevation stress, 
NI-mPFC projection neurons are activated and synapse onto mPFC neurons 
inhibiting mPFC neuronal firing, and leads to the HP-mPFC LTP suppression (Fig 
4.4A). On one hand, when pre-infused with CRF1 antagonist into NI before elevation 
stress, the NI neurons would not be activated during stress, hence NI-mPFC 
projection neurons have no effect on mPFC (Fig 4.4B). On the other hand, when 
CRF1 antagonist is infused after elevation stress and before HFS, although during 
stress the NI neurons are activated and would modulate mPFC neurons, after intra-NI 
CRF1 antagonist infusion, the activation of the NI-mPFC projection neurons would be 
stopped and their control over mPFC neurons would also be ceased. Therefore, upon 
HFS, the HP-mPFC LTP could still be induced (Fig 4.4C). However, comparing to 
non-stress, the blockade of LTP suppression was incomplete, it might because other 
structures are also responding to stress and suppress LTP. For example, VTA is 
another major structure modulating mPFC by dopaminergic innervation in response 
to stress (Bissonette et al., 2013). It is important to mention that, although the NI 
projects heavily to hippocampal formation, very sparse NI neurons output to CA1 and 
subiculum regions (Goto et al., 2001). Thus, the suppression of HP-mPFC LTP is less 
likely to be caused by the NI modulation of hippocampal neurons, but more likely 
initiated by NI-mPFC regulation.  
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Notwithstanding the significant induction of HP-mPFC LTP when treated with CRF1 
antagonist in the stressed rats, the increased sample numbers in both pre- and 
post-elevation stress antagonist infusion groups would strengthen our hypothesized 
model. In addition, proper control groups of intra-NI saline infusion pre- and 
post-stress are important. Further study should also examine the dosage response of 
NI in HP-mPFC LTP modulation by varying the dosage of intra-NI antalarmin 
infusion. To exclude the possibility that the effects on HP-mPFC LTP is cause by the 
antalarmin diffusion to the NI nearby structures, like dorsal raphe nucleus (DRN), 
control antalarmin infusion into the DRN and effects on HP-mPFC LTP after 
exposure to elevation stress would be studied. Moreover, to have a better 
understanding of the mechanism of NI-mPFC modulation under stress and the 
potential neurotransmitter systems involved, RLN3 could be directly infused into 
mPFC to test the effect on HP-mPFC LTP. Also, D2 antagonists and CRF could be 
sequentially infused into the NI to examine the effects on HP-mPFC LTP. The 
detailed elucidation of the mechanism of the role of NI in stress-induced mPFC 
modulation could indicate the NI or the related neurotransmission as potential 
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Chapter 5  




1.1 Prefrontal cortex and working memory 
The PFC plays a major role in mediating executive functions, including working 
memory, temporal processing, planning, flexibility, and decision making (Kesner and 
Churchwell, 2011). Working memory is a process for temporary retention and 
manipulation of information that was recently acquired but no longer exists in the 
external environment, or was just retrieved from long-term storage (D’Esposito, 2007; 
Godman-Rakic, 1995). PFC generated representational knowledge could be stored for 
a short period of time, but could be prolonged via active maintenance or rehearsal 
(D’Esposito. 2007). Therefore, PFC is the key site for inhibiting inappropriate actions 
and promoting goal-directed behaviors by protecting the fragile representations from 
the interference of external or internal distractions (Arnsten, 2009).  
 
The PFC in humans and non-human primates has been intensively studied, whereas 
there was comparably less study in rodents. However, the rodent PFC provides an 
invaluable model system for understanding prefrontal executive functions in general 
(Uylings et al., 2003). Anatomically, the rodent PFC is divided into anterior cingulate 
cortices (ACC), medial PFC (mPFC) which is comprised of prelimbic (PL) and 
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infralimbic (IL) cortices, and orbital PFC (Holmes and Wellman, 2009). Although 
ACC is often considered a sub-region of mPFC, along with PL and IL, we categorize 
them as different brain areas in terms of their major differences in functions 
(Bissonette et al., 2013). Comparing the rodent and primate PFC, the ACC and mPFC 
have a functional homology with the primate dorsolateral and ventromedial PFC, 
while the OFC has similar features as the primate orbital PFC (Holmes and Wellman, 
2009). Whether in rodents or primates, the PFC plays a crucial role in brain wide 
orchestration of adaptive behaviors.  
 
With respect to working memory, ACC is involved in processing of motor response 
information, while mPFC plays an important role in working memory for visual 
object and spatial location information (Ragozzino and Kesner, 2001; Horst and 
Laubach, 2009). In this project, we mainly focus on the working memory function of 
mPFC. Direct evidence comes from lesion studies. Studies show that lesions of 
mPFC, specifically PL and IL, lead to deficits in working memory in the aspects of 
visual object and spatial information (Horst and Laubach, 2009; Di Pietro et al., 2004). 
Further, sustained or increased neural firing in the mPFC was observed in the delay 
period, which is the memory retention interval, in the delayed matching-to-position 
task and delayed spatial alternation task (Chang et al., 2002; Baeg et al., 2003). 
 
1.2 mPFC working memory behavior paradigms 
Animal models have been used extensively in prefrontal working memory function 
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study, usually in the context of a task that involves spatial information. The tasks 
usually fall into two categories, spatial delayed response and spatial search tests 
(Yogita Chudasama, 2011). For spatial delayed response, spatial delayed alternation 
task in T-maze or Y-maze and delayed non-match to sample task are widely used in 
assessing working memory in rodents (Dudchenko, 2004; Aggleton et al., 1995). In a 
delayed alternation T-maze task, the rat must retain the information of the two 
different locations online and alternate its spatial response between left and right arms 
in successive trials separated by a delay period (Zahrt et al., 1997). Studies showed 
that rats with mPFC lesions showed significant impairments in the task, whereas 
control rats perform high accuracy (Kolb et al., 1974; Larsen and Divac, 1978). 
However, delayed response has its limitations. It only focuses on the working 
memory that maintain information online but fail to account for the aspects of 
working memory that related to changes in strategy or the organized sequencing of 
responses (Chudasama, 2011). To solve this problem, the higher complexity of 
working memory could be assessed by foraging tasks such as radial arm maze. In any 
given trial, only some of the arms are baited. The rats are required to remember the 
arms that had been previously visited and, after a delay period, enter the arms that 
were previously unbaited (Packard et al., 1989; Floresco et al., 1997). Control rats 
perform well in the task, while mPFC lesion rats make a large number of random 
searching errors (Seamans et al, 1995). Here, to determine whether NI plays a role in 
modulation of mPFC working memory, no matter whether in the aspects of retention 
of information, or the update to changed strategy, delayed spatial win-shift task 
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(SWSh) in an eight-arm radial arm maze was applied. 
 
1.3 Stress and mPFC working memory 
As mentioned above, mPFC subserves higher cognitive functions, such as working 
memory. However, it is one of the brain region that is most sensitive to stress. Even 
brief periods of intense stress are sufficient to cause rapid and dramatic detrimental 
effects on prefrontal executive abilities in working memory, attentional set-shifting 
and cognitive flexibility, and emotional dysregulation (Arnsten, 2009; Holmes and 
Wellman, 2009). Prolonged stress exposure leads to the alterations in mPFC neuronal 
morphology in rodents, and growing evidence has revealed that stress-induced 
structural remodeling of mPFC neurons is associated with deficits in rodent executive 
functions (Holmes and Wellman, 2009). A number of studies have examined the 
effects of stress on mPFC mediated working memory. Impaired working memory was 
observed in Morris Water maze (MWM), radial arm maze, and delayed alternation 
T-maze tasks upon chronic unpredictable stress (CUS) exposure (Graybeal et al., 
2012). Surprisingly, single exposure to an acute stress, such as 15min tail-pinch, 
30min predatory stress and 10min open field, is sufficient to impair mPFC working 
memory examined by delayed non-match to sample, delayed alternation water 
T-maze, or delayed win-shift radial maze tasks (Butts et al., 2011; Woodson et al., 
2003; Del Arco et al., 2007). Nonetheless, there are also reports of no effect of stress, 
or even facilitation of working memory after exposure to brief restraint or forced 
swim stress (Choy et al., 2008; Yuen et al., 2009). One important aspect to note is 
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that acute or chronic corticosterone treatment, or glucocorticoid receptor agonist 
infusion into the PL also impairs mPFC working memory performance, and the 
detrimental effects are similar to mPFC lesion-induced PFC dysfunction (Bardgett et 
al., 1994; Roozendaal et al., 2004). Moreover, consistent with stress effects, 
glucocorticoid activity causes changes in neuronal morphology in the mPFC, such as 
dendritic retraction (Cerqueira et al., 2007b). Therefore, in this study, since we would 
like to determine whether the NI plays a role in modulation of mPFC-dependent 
working memory behavior modulation, intra-NI CRF treatment followed by delayed 
SWSh task was used to test our hypothesis. 
 
2. Materials and Methods 
2.1 Animals and surgery 
Adult male SD rats (290-330g) were habituated 2-3 days in standard housing 
conditions before experiments. During surgery, similarly, a guide cannula was 
implanted targeting the NI with a dummy cannula inserted. The rats were 
rehabilitated for 2 weeks before food restriction. 
 
2.2 Food restriction 
Two weeks after surgery, the free feeding weight of the rats was recorded. The rats 
were food restricted to 90% of their free feeding weight, and the food restriction 
maintained until the end of the duration of experiments. 
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2.3 Radial arm maze task 
An eight-arm radial maze was used for the experiment. The maze was elevated 80cm 
from the floor. It had an octagonal center platform 30cm in diameter projecting to 
eight arms at equal angles (45 cm x 16cm x 23cm). The maze was located in a room 
with numerous extra maze cues that remained in constant positions throughout the 
duration of the experiments, which was evenly illuminated with diffuse light. The 
maze was randomly rotated twice a week to minimize the intra-maze cues. 
 
The Delayed Spatial Win-Shift (SWSh) task was applied here. This task was adapted 
from Floresco et al. (1997). Two weeks after surgery, the rats were habituated to the 
maze environment for 3 days. Rats were placed on the center platform and allowed to 
explore freely for 10min/day. Subsequent training trials were given once daily. The 
trials consisted of a training phase, a delay period, and a testing phase. During the 
training phase, a random set of four arms was blocked, while the remaining four arms 
were baited with food reward (1/4 fruit loop per arm, Kellogg's Fruit Loops Cereal) at 
the end of each arm. The rats were released on the center of the platform and 
remained in the maze until retrieval of all four food pellets or 5 min past. The rats 
were then returned to their home cage undisturbed for a delay period. During the 
testing phase, all eight arms were open. The previous blocked arms contain food 
reward, while the previous baited arms were empty. Again, upon retrieval of the four 
pellets or 5 min past, the rats were removed from the maze. The errors in the testing 
phase were recorded. There were two error types. An across-phase error was defined 
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as any initial entry into an arm that had been entered previously during the training 
phase, and a within-phase error was defined as any reentry into an arm that had been 
entered in the retrieval phase. An arm was considered entered when the center of the 
rat crossed halfway down the distance of the arm. The initial delay period was 5 min. 
After achieving the criterion performance in which all four pellets were retrieved in 
five or fewer errors for two consecutive days, the delay period was increased to 15 
min. The drug infusion and testing were performed after attaining two consecutive 
days of criterion performance at a 15 min delay. The maze was thoroughly wiped 
with 70% ethanol between each rat and between each phase. 
2.4 Drug treatments 
The rats were divided into two groups, with 1μg CRF (human, rat; Tocris) treatment 
or with vehicle treatment. In Experiment 1, the CRF or vehicle was administered 
before training phase. 0.1μl solution was delivered in 30s and the infusion cannula 
was left in place for 1 min before placing the rat in the maze. The rats were 
habituated to mock infusion until arrived at the criterion before Experiment 1. In 
Experiment 2, the drugs were infused before testing phase. Similarly, the rats were 
habituated to mock infusion before experiment 2, but the mock infusion was 
performed before testing phase instead of training phase. The CRF and the vehicle 
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Figure 5.1 Role of NI in stress-induced mPFC working memory behavior modulation.  
(A) Percentage of rats achieved all four food pellets within 5 or less choices, in the time course of 15 min 
delay SWSh task training, showing a trend of improvement in performance along the training (B) Number 
of errors in the testing phase of the saline and CRF treatment groups in the injection day and the same 
animals in the day prior injection. CRF treatment has a trend of more errors made in the injection day 
than saline group, however not significant. (C) Number of across-phase errors and within-phase errors in 
saline and CRF treatment groups in the injection day. No significant effect on error types in CRF 
treatment comparing to saline treatment, while significant difference in error type within CRF treatment. 
Errors are represented by mean±sem. *P<0.05 
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3. Results 
3.1 Performance along delayed SWSh task training 
To investigate whether NI plays a role in mPFC working memory behavior 
modulation, delayed SWSh task in a radial arm maze was conducted. The rats were 
first trained to learn the task. The training record of 15 min delay SWSh task showed 
that, generally, there was a trend of increasing correct responsiveness along the 
training time course (Fig5.1A). Here, “correct” was defined as the criterion of 
achieving the four food pellets in the testing phase with no more than one error. The 
results were represented by the percentage of the correct responding rats within the 
particular training day.  
 
3.2 Role of NI in stress-induced mPFC working memory behavior modulation  
When the rats arrived at the criterion for two consecutives days, the rats were 
subjected to testing the next day, with either intra-NI CRF or saline infusion 3 min 
before the training phase. As shown in Fig 5.1B, the data was represented by the 
errors occurred in the testing phase, also named as retrieval phase, of the two 
treatment groups in the day prior injection (only mock injection) and the injection day. 
Two-way ANOVA indicated that CRF treatment had no significant effect on delayed 
SWSh task performance, nevertheless, a trend of more errors made in CRF treatment 
group then saline group was observed. Results also showed that both groups made 
more errors in the injection day then the day prior, which would be discussed later. A 
more detailed comparison in the specific error types of across-phase error and 
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within-phase error by two-tailed Student’s t-test indicated that comparing CRF and 
saline injections, the treatment had no significant effect on the types on errors made 
(Fig 5.1C). However, there was a significant difference in the types of errors within 
the CRF treatment group (p=0.045). Considering the locomotion, two-way ANOVA 
illustrated that there were no significant differences in latencies to reach the first food 
cup or velocity between the treatments. Therefore, our results implicated that the NI 
might play a mild role in mPFC working memory behavior modulation, although the 
current study has some limitations and further studies are required.  
 
4. Discussion 
4.1 Role of NI in stress-induced mPFC working memory behavior modulation 
The evidence mentioned in the previous chapters demonstrated that the NI may play a 
role in mPFC modulation under stress tested by in vivo electrophysiology in 
anaesthetized rats. The next stage we carry on to investigate is the potential role of 
the NI in stress-induced mPFC working memory modulation with behavioral 
paradigms in moving animals. Although a trend of more retrieval errors was observed 
in the pre-training CRF treatment group as compared to saline group on the actual 
injection day, the difference was not significant. Unexpectedly, both groups showed 
more errors in the injection day then the day prior. This unexpected result of saline 
treatment group might because the number of animals per group was too small, while 
animal behavior usually varies between individuals. Our results implicated a trend of 
mild impairment of accurate recall of the representational knowledge in mPFC under 
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stress, hence the NI might play a mild role in mPFC working memory behavior 
modulation in stress conditions. However, because of the limitations in this work, 
improved studies should be carried out to verify the findings.  
 
Some obstacles were encountered in the experiments that suggest the need for further 
replication. The sample size was not sufficient. Only 16 rats were involved in the 
original training, but as quite a few of the rats could not learn the task after long-term 
training, hence the final number for testing was small (n=3 to 6 per group). Second, 
the timing of testing may not have been optimal. The planned test timing was when 
all the rats had arrived at the criterion for at least two consecutive days. However, 
there were individual differences in task learning speed between the rats. If the 
experiment is repeated, it would be advisable to test each animals whenever it 
achieved the criterion for two consecutive days rather than waiting to test all the 
animals in one cohort.  
 
Future studies would use easier learned or easier manipulated mPFC working 
memory behavior tasks, eg. delayed alternation T-maze task and trial-unique delayed 
nonmatching-to-location (TUNL) task using touch screen (Zahrt et al., 1997; 
McAllister et al., 2013). Furthermore, the number of rats trained would be increased 
to have a sufficient sample size for testing. In addition, an infusion tube with a 
smaller volume of about 2μl could be used for CRF infusion to ensure more reliable 
and efficient CRF infusion wasting less CRF in the infusion tube dead space. To 
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speak further, both pre-training CRF infusion and pre-testing CRF infusion would be 
tested to examine whether stress time point, namely stress during the acquisition or 
retrieval phase of working memory, is also a determinant in stress-induced mPFC 
modulation by NI functioning (Sandi and Pinelo-Nava, 2007). After that, a more 
profound investigation of the role of NI in mPFC working memory behavior 
modulation would be conducted, focusing on two aspects. First, whether stressors like 
elevation and swimming stress models used in this study would impair the mPFC 
function through NI regulation. The rats would be exposed to stressors and tested in 
mPFC behavior task with either intra-NI antalarmin or saline infusion. Second, the 
potential involved neurotransmitter systems involved would be verified by in vivo 
electrophysiology and would be further studied in behavior tasks. Our lab is currently 
trying to establish the optogenetics technology (Zhang et al., 2010) for NI study. 
Successful establishment would allow the instant manipulation of NI neuronal firing 
during behavior studies and open a large possibility for the study of NI functions. 
 





Figure 6.1 Conclusion and schematic model of role of NI in mPFC modulation under stress 
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Chapter 6  
Conclusions 
 
Our study has demonstrated the critical role of NI in PFC modulation under stress, 
especially in mPFC working memory modulation (Fig 6.1). The previous study from 
our laboratory revealed that both NI electrical stimulation and intra-NI CRF infusion 
lead to suppressed mPFC neuron firing and HP-mPFC LTP, but increased ACC 
neuron firing. 
 
In Chapter 3, the expression of CRF1, RLN3 and dopamine D2S in NI-mPFC and 
NI-ACC projection neurons was characterized. Almost all projection neurons express 
the three neuromodulators, illustrating that NI neurons may directly modulate PFC in 
response to stress. Furthermore, RLN3 and D2S may involve in the modulation 
process. In addition, the advanced brain tissue clearing and imaging technology 
CLARITY was preliminary established in our lab for further studies on NI 
connections and chemoarchitecture. 
 
In Chapter 4, the role of NI in stressor-induced mPFC modulation, especially the 
effects on HP-mPFC LTP was demonstrated. First, the optimal stress models of 
elevation stress and swim stress were established. After that, in vivo 
electrophysiology study of the rats exposed to elevation stress revealed that CRF1 
antagonist – antalarmin treatment, both pre-stress injection and pre-HFS injection 
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could induct the HP-mPFC LTP, blocking the suppression effect on the pathway 
caused by elevation stress, suggesting that NI is activated under stress and results in 
the mPFC impairment.  
 
In Chapter 5, the role of NI in stress-induced mPFC working memory behavior 
modulation was investigated. The effects of intra-NI CRF treatment, as a mimic of 
stress conditions, on mPFC working memory performance was examined in a delayed 
SWSh task in a radial arm maze. The results indicated a possible mild impairment in 
mPFC working memory performance by NI activation and modulation under stress. 
 
In conclusion, the NI may play an important role in PFC modulation, especially 
mPFC working memory intervention, in response to stress. NI might be a potential 
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